the National List of Essential Medicines

X.11035/346/2021-DRS Government ofIndia Ministry of Health and Family Welfare

Nirman Bhavan,New Delhi Dated 13^September,2022

The Government of India had constituted a Core Committee under the Chairmanship of Dr. V.M. Katoch the then Secretary, Department of health ResearchandDirectorGeneral,ICMR,MinistryofHealth& FamilyWelfarefor reviewingand revisingtheNationalListofEssentialMedicines(NLEM),2011 in the context of contemporary knowledge of use of therapeutic products. The Core Committee sincesubmitted itsreportand the Government ofIndia accepted the recommendations and adopted the National List of Essential Medicines

(NLEM),2015 along with otherrecommendations.

2. Subsequently, the Standing National Committee on Medicines(SNCM) constitutedvideorderdated 03.07.2018toreviewandrevisetheNationalListof EssentialMedicinesbywayofadditionsanddeletionsintheexistingNLEM in the context of contemporary knowledge of use of therapeutic products in health & hygieneofgeneralpublic.ThecommitteewasheadedbySecretary,DHR/DG, ICMR.

3.TheSNCM hassubmitteditsfinalreporton10.09.2022andafterexamination ofthereport,theGovernmentofIndiahasacceptedtherecommendationsofthe Committeeintotoand adoptedtheNationalListofEssentialMedicines(NLEM), 2022asrecommendedbytheSNCMalongwithotherrecommendationsas contained in the report.

4.The GovernmentofIndiahasfurtherdecidedthattheListwillbeoperational with immediate effect.

V •>

(Dr.Mandeep K.Bhandari) JointSecretarytotheGovernmentofIndia.

National List of Essential Medicines 2022

Sections of Drug Classes

Table of Contents

Section 1 Medicines used in Anaesthesia ………………………………………………………………….3

Section 2 Analgesics, Antipyretics, Non-steroidal Anti-inflammatory

Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders…………………………………………………………………..6

Section 3 Antiallergics and Medicines used in Anaphylaxis………………………………………..9

Section 4 Antidotes and Other Substances used in Management of Poisonings/Envenomation ………………………………………………………………………11

Section5 MedicinesusedinNeurologicalDisorders……………………………………………….13

Section 6 Anti-infective Medicines…………………………………………………………………………18

Section 7 Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care……………………………………………………………………………………….37

Section 8 Medicines affecting Blood ………………………………………………………………………45 Section 9 Blood products and Plasma substitutes……………………………………………………..47 Section 10 Cardiovascular Medicines……………………………………………………………………..49 Section 11 Dermatological Medicines (Topical) ………………………………………………………54 Section 12 Diagnostic agents …………………………………………………………………………………56 Section 13 Dialysis components (Haemodialysis and Peritoneal Dialysis) ………………….57 Section 14 Antiseptics and Disinfectants…………………………………………………………………57 Section 15 Diuretics ……………………………………………………………………………………………..58 Section 16 Ear, Nose and Throat Medicines…………………………………………………………….59 Section 17 Gastrointestinal Medicines…………………………………………………………………….60 Section 18 Hormones, other Endocrine Medicines and Contraceptives……………………….63

Section 19 Section 20 Section 21 Section 22 Section 23 Section 24 Section 25

Immunologicals……………………………………………………………………………………67

Medicines for Neonatal Care …………………………………………………………………70

Ophthalmological Medicines …………………………………………………………………71

Oxytocics and Antioxytocics …………………………………………………………………73

Medicines used in treatment of Psychiatric Disorders……………………………….74

Medicines acting on the Respiratory tract ……………………………………………….78

Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances…………………………………………………………………………………………80

Section 26

Section 27

Alphabetical List of Medicines in NLEM 2022 ………………………………………………………84 Medicines Added Therapeutic category wise in NLEM 2022 …………………………………101 Alphabetical List of Medicines Added to NLEM 2022……………………………………………113 Medicines Deleted from Therapeutic category wise NLEM 2015 …………………………..116 Alphabetical List of Medicines Deleted from NLEM 2015 ……………………………………..127 INDEX 130

Vitamins and Minerals ………………………………………………………………………….81 Medicines for COVID 19 management …………………………………………………82

Section 1 Medicines used in Anaesthesia

1.1- General Anaesthetics and Oxygen

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.1.1

Halothane

S,T

Liquid for inhalation

1.1.2

Isoflurane

S,T

Liquid for inhalation

1.1.3

Ketamine

P,S,T

Injection 10 mg/mL Injection 50 mg/mL

1.1.4

Nitrous oxide

P,S,T

As licensed for medical purpose

1.1.5

Oxygen*

P,S,T

As licensed for medical purpose

1.1.6

Propofol

P,S,T

Injection 10 mg/mL

1.1.7

Sevoflurane

S,T

Liquid for inhalation

1.1.8

Thiopentone

P,S,T

Powder for injection 0.5 g Powder for injection 1 g

*Oxygen is also listed in Section 27.5 – Medicines for COVID 19 management

1.2-Local Anaesthetics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.2.1

Bupivacaine

S,T

Injection 0.25 %

Injection 0.5 %

Injection 0.5 % with 7.5 % glucose

1.2.2

Lignocaine*

P,S,T

Topical forms 2-5 %

Injection 1 %

Injection 2 %

Injection 5 % with 7.5 % glucose

1.2.3

Lignocaine (A) + Adrenaline (B)

P,S,T

Injection 1% (A) + 1:200000 (5 mcg/mL) (B)

Injection 2% (A) + 1:200000 (5 mcg/mL) (B)

1.3- Preoperative Medication and Sedation for Short Term Procedures

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.3.1

Atropine**

P,S,T

Injection 0.6 mg/mL

*Lignocaine formulations are also listed in Section 10.2.5 cardiovascular medicines- Antiarrhythmic medicines

**Atropine formulations are also listed in –

A. Section 4.2.1 – Antidotes and Other Substances used in Management of Poisonings/Envenomation – Specific

B. Section 21.5.1 – Ophthalmological Medicines- Mydriatics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.3.2

Glycopyrrolate

S,T

Injection 0.2 mg/mL

1.3.3

Midazolam*

P,S,T

Tablet 7.5 mg

Nasal Spray 0.5mg Nasal Spray 1.25 mg Injection 1 mg/mL Injection 5 mg/mL

1.3.4

Morphine**

P,S,T

Injection 10 mg/mL Injection 15 mg/mL

Section 1.4 -Muscle Relaxants and Cholinesterase Inhibitors

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.4.1

Atracurium

S,T

Injection 10 mg/mL

1.4.2

Baclofen

S,T

Tablet 5 mg Tablet 10 mg Tablet 20 mg

*Midazolam formulations are also listed in –

A. Section 5.1.7- Medicines used in Neurological Disorders Anticonvulsants/ Antiepileptics B. Section 7.4.12- Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

**Morphine formulations are also listed in –

A. Section 2.2.2- Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Opioid Analgesics

B. Section 7.4.13 – Anti-cancer agents including immunosuppressives, and medicines used in Palliative Care

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.4.3

Neostigmine*

S,T

Tablet 15 mg Injection 0.5 mg/mL

1.4.4

Succinylcholine

S,T

Injection 50 mg/mL

1.4.5

Vecuronium

S,T

Powder for injection 4 mg Powder for injection 10 mg

Section 2

Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders

2.1 – Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

2.1.1

Acetylsalicylic acid**

P,S,T

Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg

*Neostigmine formulations are also listed in Section 4.2.8 – Antidotes and Other substances used in Management of poisoning/Envenomation – Specific

**Acetylsalicylic acid formulations are also listed in –

A. Section 5.2.1 – Medicines used in Neurological Disorders Antimigraine medicines

B. Section 10.5.1 – Cardiovascular medicines -Antithrombotic Medicines (Cardiovascular/ Cerebrovascular) – Antiplatelet and Antithrombotic Medicines

2.1.2

2.1.5

2.2.1

Medicine

Diclofenac

Paracetamol**

Medicine

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Tablet 50 mg Injection 25 mg/mL

2.1.3

2.1.4

Ibuprofen*

Mefenamic acid

P,S,T

Tablet 200 mg

Tablet 400 mg

Oral liquid 100 mg/5 mL (p)

Tablet 250 mg

Oral liquid 100 mg/5 mL (p)

Tablet 500 mg

Tablet 650 mg

Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p) Injection 150 mg/ mL Suppository 80 mg Suppository 170 mg

2.2-Opioid Analgesics

Level of Healthcare

Dosage form(s) and strength(s)

Fentanyl

S,T

Injection 50 mcg/mL

*Ibuprofen formulations are also listed in Section 5.2.2 – Medicines used in Neurological Disorders-Antimigraine Medicines

** Paracetamol formulations are also listed in –

A. Section 5.2.3 – Medicines used in Neurological Disorders-Antimigraine Medicines B. Section 27.4 – Medicines for COVID 19 Management

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

2.2.2

Morphine*

P,S,T

Tablet 10 mg Injection 10 mg/mL Injection 15 mg/mL

2.2.3

Tramadol**

S,T

Capsule 50 mg Capsule 100 mg Injection 50 mg/mL

2.3-Medicines used to treat Gout

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

2.3.1

Allopurinol***

P,S,T

Tablet 100 mg Tablet 300 mg

2.3.2

Colchicine

P,S,T

Tablet 0.5 mg

*Morphine formulations are also listed in –

A. Section 1.3.4 – Medicines used in Anaesthesia – Preoperative medication and sedation for short term procedures

B. Section 7.4.13 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

** Tramadol formulations are also listed in

Section 7.4.15 – Tramadol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

*** Allopurinol formulations are also listed in

Section 7.4.1 – Allopurinol formulations are also listed in Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

2.4-Disease Modifying Agents used in Rheumatoid Disorders

2.4.2

3.2

Medicine

Azathioprine*

Sulfasalazine

Level of Healthcare

Dosage form(s) and strength(s)

2.4.1

S,T

Tablet 25 mg (p) Tablet 50 mg

Hydroxychloroquine

P,S,T

Tablet 200 mg Tablet 400 mg

2.4.3

2.4.4

Methotrexate**

P,S,T

S,T

Tablet 2.5 mg Tablet 5 mg Tablet 10 mg

Section 3

Antiallergics and Medicines used in Anaphylaxis

3.1

Medicine

Adrenaline

Cetirizine

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Injection 1 mg/mL

P,S,T

Tablet 10 mg

Oral liquid 5 mg/5 mL (p)

* Azathioprine formulations are also listed in Section 7.3.1 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

** Methotrexate formulations are also listed in Section 7.1.30 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

Tablet 500 mg

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

3.3

Dexamethasone*

P,S,T

Tablet 0.5 mg

Tablet 2 mg

Tablet 4 mg

Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL

3.4

Hydrocortisone**

P,S,T

Tablet 5 mg

Tablet 10 mg

Powder for Injection 100 mg Powder for Injection 200 mg

3.5

Pheniramine

P,S,T

Injection 22.75 mg/mL

3.6

Prednisolone***

P,S,T

Tablet 5 mg

Tablet 10 mg

Tablet 20 mg

Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p)

*Dexamethasone formulations are also listed in –

A. Section 7.4.3 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

B. Section 18.1.1 – Hormones, other Endocrine Medicines and Contraceptives – Adrenal Hormones and Synthetic Substitutes

C. Section 27.1 – Medicines for COVID 19 Management

** Hydrocortisone formulations are also listed in Section 18.1.3 – Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and Synthetic Substitutes

***Prednisolone formulations are also listed in –

A. Section 7.2.4 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Hormones and Anti-Hormones used in cancer therapy

B. Section 18.1.5 – Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and Synthetic Substitutes

C. Section 21.2.1 – Ophthalmological Medicines- Anti-inflammatory Medicine

4.1-Nonspecific

4.2.2

4.2.4

Section 4

Antidotes and Other Substances used in Management of Poisonings/Envenomation

4.1.1

Medicine

Activated Charcoal

Atropine*

Calcium gluconate**

Desferrioxamine

Level of Healthcare

P,S,T

Powder (as licensed)

4.2 Specific

4.2.1

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

Injection 0.6 mg/mL

P,S,T

S,T

Injection 100 mg/mL

4.2.3

D- Penicillamine

P,S,T

Capsule 150 mg (p) Capsule 250 mg

Powder for injection 500 mg

4.2.5

Methylthioninium chloride (Methylene blue)

S,T

Injection 10 mg/mL

*Atropine formulations are also listed in –

A. Section 1.3.1 – Medicines used in Anaesthesia -Preoperative Medication and Sedation for short term procedures

B. Section 21.5.1 – Ophthalmological Medicines- Mydriatics

** Calcium gluconate formulations are also listed in Section 26.3 – Vitamins and minerals

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

4.2.6

N-acetylcysteine

P,S,T

Sachet 200 mg Injection 200 mg/mL

4.2.7

Naloxone

P,S,T

Injection 0.4 mg/mL

4.2.8

Neostigmine*

P,S,T

Injection 0.5 mg/mL

4.2.9

Pralidoxime chloride (2-PAM)

P,S,T

Injection 25 mg/mL

4.2.10

Snake venom antiserum**

P,S,T

Soluble/ liquid polyvalent – As licensed

Lyophilized polyvalent – As licensed

4.2.11

Sodium nitrite

S,T

Injection 30 mg/mL

4.2.12

Sodium thiosulphate

S,T

Injection 250 mg/mL

* Neostigmine formulations are also listed in Section 1.4.3 – Medicines used in Anaesthesia – Muscle relaxants and cholinesterase inhibitors

** Snake Venom antiserum is also listed in Section 19.2.7. – Immunologicals – Sera and immunoglobulins (Liquid/ Lyophilized)

Section 5

Medicines used in Neurological Disorders

Section 5.1-Anticonvulsants/ Antiepileptics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.1.1

Carbamazepine*

P,S,T

Tablet 100 mg Tablet 200 mg Tablet 400 mg

Modified Release – Tablet 200 mg Tablet 400 mg

Oral liquid 100 mg/5 mL (p)

5.1.2

Clobazam

S,T

Tablet 5 mg Tablet 10 mg

5.1.3

Diazepam**

P,S,T

Oral liquid 2 mg/5 mL (p) Injection 5 mg/mL Suppository 5 mg

5.1.4

Levetiracetam

S,T

Tablet 250 mg Tablet 500 mg Tablet 750 mg

Modified Release Tablet 750 mg Oral liquid 100 mg/mL (p) Injection 100 mg/mL

5.1.5

Lorazepam

P,S,T

Tablet 1 mg Tablet 2 mg Injection 2 mg/mL Injection 4 mg/mL

*Carbamazepine formulations are also listed in Section 23.2.2.3 Medicines used in treatment of Psychiatric disorder – Medicines used in Bipolar disorders

** Diazepam formulations are also listed in Section 7.4.4 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Medicines used in Palliative Care

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.1.6

Magnesium sulphate

S,T

Injection 500 mg/mL

5.1.7

Midazolam*

P,S,T

Tablet 7.5 mg

Tablet 15 mg

Nasal Spray 0.5 mg/actuation Nasal Spray 1.25 mg/actuation Injection 1 mg/mL

Injection 5 mg/mL

5.1.8

Phenobarbitone

P,S,T

Tablet 30 mg

Tablet 60 mg

Oral liquid 20 mg/5 mL (p)

S,T

Injection 200 mg/mL

5.1.9

Phenytoin

P,S,T

Tablet 50 mg

Tablet 100 mg

Tablet 300 mg

Modified Release Tablet 300 mg Oral liquid 30 mg/5 mL (p)

Oral liquid 125 mg/5 mL (p) Injection 25 mg/mL Injection 50 mg/mL

*Midazolam formulations are also listed in –

A. Section 1.3.3 – Medicines used in Anaesthesia – Preoperative Medication and Sedation for short term procedures

B. Section 7.4.12 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Medicines used in Palliative Care

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.1.10

Sodium Valproate*

P,S,T

Tablet 200 mg Tablet 300 mg Tablet 500 mg

Modified Release – Tablet 300 mg Tablet 500 mg

Oral liquid 200 mg/5 mL (p)

S,T

Injection 100 mg/mL

Section 5.2- Antimigraine Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.2.1

Acetylsalicylic acid**

P,S,T

Tablet 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg

*Sodium Valproate formulations are also listed in-

Section 23.2.2.2 – Medicines used in treatment of Psychiatric Disorders -Medicines used in Bipolar disorders- Medicines used in mood disorders

**Acetylsalicyclic acid formulations are also listed in –

A. Section 2.1.1 – Analgesics, Antipyretics, Non-steroidal Anti-inflammatory

Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

B. Section 10.5.1 – Cardiovascular medicines- Antiplatelet and Antithrombotic Medicines

Medicine

Sumatriptan

Level of Healthcare

Dosage form(s) and strength(s)

5.2.2

Ibuprofen*

P,S,T

Tablet 200 mg

Tablet 400 mg

Oral liquid 100 mg/5 mL (p)

5.2.3

5.2.4

Paracetamol**

P,S,T

Tablet 500 mg

Tablet 650 mg

Oral liquid 120 mg/5mL (p) Oral Liquid 125 mg/5mL (p) Oral Liquid 250 mg/5mL (p)

P,S,T

Tablet 25 mg Tablet 50 mg

Section 5.2.1 – For Prophylaxis

5.2.1.1

Amitriptyline***

P,S,T

Tablet 10 mg Tablet 25 mg Tablet 75 mg

*Ibuprofen formulations are also listed in Section 2.1.3 – Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

**Paracetamol formulations are also listed in –

A. Section 2.1.5 – Analgesics, Antipyretics, Non-steroidal Anti-inflammatory

Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Non-opioid analgesics, antipyretics and nonsteroidal anti- inflammatory medicines

B. Section 27.4 – Medicines for COVID 19 management

*** Amitriptyline formulations are also listed in –

A. Section 7.4.2 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Medicines used in Palliative Care-

B. Section 23.2.1.1 – Medicines used in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.2.1.2

Flunarizine

P,S,T

Tablet 5 mg Tablet 10 mg

5.2.1.3

Propranolol

P,S,T

Tablet 10 mg Tablet 20 mg Tablet 40 mg

Section 5.3- Antiparkinsonism Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.3.1

Levodopa (A) + Carbidopa (B)

P,S,T

Tablet 100 mg (A) + 10 mg (B) Tablet 100 mg (A) + 25 mg (B) Tablet 250 mg (A) + 25 mg (B)

Modified Release –

Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B)

5.3.2

Trihexyphenidyl

P,S,T

Tablet 2 mg

Section 5.4-Medicines used in Dementia

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

5.4.1

Donepezil

S,T

Tablet 5 mg Tablet 10 mg

Section 6 Anti-infective Medicines

6.1-Anthelminthics

6.1.1- Intestinal Anthelminthics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.1.1.1

Albendazole*

P,S,T

Tablet 400 mg

Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p)

6.1.1.2

Mebendazole

P,S,T

Tablet 100 mg

Oral liquid 100 mg/5 mL (p)

6.1.2 Antifilarial

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.1.2.1

Albendazole*

P,S,T

Tablet 400 mg

Chewable Tablet 400 mg Oral liquid 200 mg/5 mL (p)

6.1.2.2

Diethylcarbamazine (DEC)

P,S,T

Tablet 50 mg

Tablet 100 mg

Oral liquid 120 mg/5 mL (p)

* Albendazole formulations are also listed Section 6.1.1.1 – in Anti-infective Medicines- Antifilarial

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.1.2.3

Ivermectin

P,S,T

Tablet 6 mg Tablet 12 mg

6.1.3 – Anti-schistosomal and Anti-trematodal Medicine

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.1.3.1

Praziquantel

S,T

Tablet 600 mg

6.2-Antibacterials

6.2.1 Beta-lactam Medicines

Medicine

Level of Healthcare

6.2.1.1

Amoxicillin

P,S,T

Capsule 250 mg

Capsule 500 mg

Oral liquid 125 mg/5 mL (p) Oral liquid 250 mg/5 mL (p) Powder for Injection 250 mg Powder for Injection 500 mg Powder for injection 1000 mg

6.2.1.2

Amoxicillin (A) + Clavulanic acid (B)

P,S,T

Tablet 500 mg (A) + 125 mg (B) Oral liquid 200 mg (A) + 28.5 mg (B)/5 mL (p)

Dry Syrup 125 mg (A) + 31.25 (B)/ 5 mL (p)

S,T

Powder for Injection 500 mg (A) + 100 mg (B)

Powder for Injection 1 g (A) + 200 mg (B)

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.2.1.3

Ampicillin

P,S,T

Powder for Injection 500 mg Powder for Injection 1000 mg

6.2.1.4

Benzathine benzylpenicillin

P,S,T

Powder for Injection 6 lac units Powder for Injection 12 lac units Powder for injection 24 lac units

6.2.1.5

Benzylpenicillin

P,S,T

Powder for injection 5 lac units Powder for injection 10 lac units

6.2.1.6

Cefadroxil

P,S,T

Tablet 500 mg

Tablet 100 mg

Oral liquid 125 mg/5 mL (p)

6.2.1.7

Cefazolin

P,S,T

Powder for Injection 500 mg Powder for Injection 1000 mg

6.2.1.8

Cefixime

S,T

Tablet 200 mg

Tablet 400 mg

Oral liquid 50 mg/5 mL (p) Oral liquid 100 mg/5 mL (p)

6.2.1.9

Cefotaxime*

S,T

Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg

*Cefotaxime formulations are also listed in Section 6.7.5.2 – Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV

6.2.1.10

6.2.1.11

Medicine

Ceftazidime

Level of Healthcare

S,T

Powder for Injection 250 mg Powder for Injection 1000 mg

Ceftriaxone

S,T

Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg Powder for Injection 2000 mg

6.2.1.12

6.2.1.13

6.2.1.14

Cloxacillin

Meropenem

P,S,T

Capsule 250 mg

Capsule 500 mg

Oral Liquid 125 mg/5 mL (p) Powder for Injection 250 mg

Piperacillin (A) + Tazobactam (B)

Powder for Injection 1000 mg (A) + 125 mg (B)

Powder for Injection 2000 mg (A) + 250 mg (B)

Powder for Injection 4000 mg (A) + 500 mg (B)

Powder for Injection 500 mg (as trihydrate)

Powder for Injection 1000 mg (as trihydrate)

Dosage form(s) and strength(s)

6.2.2 – Other Antibacterials

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.2.2.1

Azithromycin*

P,S,T

Tablet 250 mg

Tablet 500 mg

Oral liquid 200 mg/5 mL (p) Powder for Injection 500 mg

6.2.2.2

Cefuroxime

P,S,T

Tablet 500 mg

Oral liquid 125 mg/ 5 mL (p) Injection 1500 mg

*Azithromycin formulations are also listed in Section 6.7.6.1 Anti-infective Medicines – Medicines used in the management of HIV- Additional Medicines for Syndromic Management of Sexually Transmitted Infections

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.2.2.3

Ciprofloxacin*

P,S,T

Tablet 250 mg

Tablet 500 mg

Oral liquid 250 mg/ 5 mL (p) Injection 200 mg/ 100 mL

6.2.2.4

Clarithromycin**

S,T

Tablet 250 mg

Tablet 500 mg

Oral liquid 125 mg/5 mL (p)

6.2.2.5

Clindamycin***

P,S,T

Capsule 150 mg Capsule 300 mg Injection 150 mg /mL

6.2.2.6

Co-trimoxazole [Sulphamethoxazole (A) +

Trimethoprim (B)]****

P,S,T

Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) + 40 mg (B)/5 mL (p)

* Ciprofloxacin formulations are also listed in –

A. Section 16.2 – Ear, Nose and ThroatMedicines,

B. Section 21.1.2 – Ophthalmological Medicines- Anti-infective Medicines,

** Clarithromycin formulations are also listed in Section 6.4.3 – Anti-infective medicines- Anti-tuberculosis Medicines

***Clindamycin formulations are also listed in –

A. Section 6.7.5.3 – Anti-infective Medicines- Antiviral Medicines- Medicines for treating Opportunistic Infections in People living with HIV

B. Section 6.9.3.1 – Anti-infective Medicines- Drugs for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines

C. Section 6.10.1.5 – Anti-infective Medicines- Antimalarial medicines- For curative treatment

**** Co-trimoxazole formulations are also listed in Section 6.9.3.2 – Anti-infective Medicines- Medicines for amoebiasis and other parasitic infections -Antipneumocystosis and antitoxoplasmosis medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.2.2.7

Doxycycline*

P,S,T

Capsule 100 mg

Dry Syrup 50 mg/5 mL (p) Power for Injection 100 mg

6.2.2.8

Gentamicin

P,S,T

Injection 10 mg/mL Injection 40 mg/mL

6.2.2.9

Metronidazole**

P,S,T

Tablet 200 mg

Tablet 400 mg

Oral liquid 200 mg/5 mL (p) Injection 500 mg/100 mL

6.2.2.10

Nitrofurantoin

P,S,T

Tablet 100 mg

Oral liquid 25 mg/5 mL (p)

6.2.2.11

Phenoxymethyl penicillin

P,S,T

Tablet 250 mg

6.2.2.12

Procaine Benzylpenicillin

P,S,T

Powder for injection 1000 mg (=1 million IU)

6.2.2.13

Vancomycin

S,T

Capsule 125 mg

Capsule 250 mg

Powder for Injection 250 mg Powder for Injection 500 mg Powder for Injection 1000 mg

*Doxycycline formulations are also listed in Section 6.10.2.1 – Anti-infective Medicines- Antimalarial medicines- For prophylaxis

**Metronidazole formulations are also listed in Section 6.9.1.1 – Anti-infective Medicines – Antiprotozoal Medicines – Medicines for amoebiasis and other parasitic infections

6.3 – Antileprosy Medicines

6.3.1

Medicine

Level of Healthcare

Clofazimine*

P,S,T

Capsule 50 mg Capsule 100 mg

6.3.2

6.3.3

Dapsone

Rifampicin**

P,S,T

Tablet 50 mg Tablet 100 mg

Capsule 150 mg Capsule 300 mg

6.4-Antituberculosis Medicines

6.4.1

6.4.3

Medicine

Amikacin

Bedaquiline

Level of Healthcare

S,T

Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL

6.4.2

Tablet 100 mg

Clarithromycin***

S,T

Tablet 250 mg Tablet 500 mg Tablet 750 mg

*Clofazimine formulations are also listed Section 6.4.5 – Anti-infective Medicines – Anti-tuberculosis medicines

**Rifampicin formulations are also listed in Section 6.4.15 – Anti-infective Medicines – Anti-tubercular medicine

***Clarithromycin formulations are also listed in Section 6.2.2.4 – Anti-infective Medicines- Antibacterials -Other Antibacterials

Dosage form(s) and strength(s)

6.4.4

6.4.6

6.4.8

6.4.10

Medicine

Clofazimine*

Cycloserine

Ethionamide

Isoniazid

Levofloxacin

Level of Healthcare

S,T

Dosage form(s) and strength(s)

Capsule 50 mg Capsule 100 mg

6.4.5

S,T

Capsule 125 mg Capsule 250 mg

Delamanid

Tablet 50 mg

6.4.7

Ethambutol

P,S,T

Tablet 200 mg Tablet 400 mg Tablet 600 mg Tablet 800 mg

Tablet 125 mg Tablet 250 mg

6.4.9

P,S,T

Tablet 100 mg

Tablet 300 mg

Oral Liquid 50 mg/5 mL (p)

P,S,T

Tablet 250 mg Tablet 500 mg Tablet 750 mg

6.4.11

6.4.12

Linezolid

Moxifloxacin

P,S,T

Tablet 300 mg Tablet 600 mg

*Clofazimine formulations are also listed in Section 6.3.1 – Anti-infective Medicines – Antileprosy medicines

Tablet 400 mg

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.4.13

Para- aminosalicylic acid

S,T

Granules (As licensed)

6.4.14

Pyrazinamide

P,S,T

Tablet 500 mg

Tablet 750 mg

Tablet 1000 mg

Tablet 1500 mg

Oral liquid 250 mg/5 mL (p)

6.4.15

Rifampicin*

P,S,T

Capsule 150 mg

Capsule 300 mg

Capsule 450 mg

Capsule 600 mg

Oral liquid 100 mg/ 5 mL (p)

6.4.16

Streptomycin

P,S,T

Powder for Injection 750 mg Powder for Injection 1000 mg

6.5 – Antifungal Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.5.1

Amphotericin B**

S,T

a) Amphotericin B (conventional) – Injection 50 mg/vial

b) Lipid Amphotericin B – Injection 50 mg/vial

c) Liposomal Amphotericin B – Injection 50 mg/vial

*Rifampicin formulations are also listed in Section 6.3.3 – Anti-infective Medicines- Antileprosy medicines

**Amphotericin B formulations are also listed Section 6.9.2.1 – Anti-infective Medicines Antileishmaniasis medicines

6.5.3

6.5.4

6.5.5

6.5.6

6.5.7

6.5.8

Medicine

Fluconazole

Griseofulvin

Itraconazole

Mupirocin

Nystatin

Level of Healthcare

P,S,T

S,T

P,S,T

S,T

Dosage form(s) and strength(s)

6.5.2

Clotrimazole*

P,S,T

Pessary 100 mg

Tablet 50 mg

Tablet 100 mg

Tablet 150 mg

Tablet 200 mg

Tablet 400 mg

Oral liquid 50 mg/ 5 mL (p)

Tablet 125 mg Tablet 250 mg Tablet 375 mg

Capsule 100 mg Capsule 200 mg

Oral liquid 10 mg/mL

P,S,T

Ointment 2%

S,T

Pessary 1 Lac IU

Oral Liquid 1 Lac IU/mL (p)

Terbinafine

P,S,T

Cream 1%

*Clotrimazole formulations are also listed in –

A. Section 6.7.5.4 – Anti-infective Medicines Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV

B. Section 11.1.1 – Dermatological Medicines (Topical)- Antifungal medicines

C. Section 16.3 – Ear, Nose and Throat Medicines

Injection 200 mg / 100 mL

6.6 – Antiviral Medicines 6.6.1 – Antiherpes Medicines

6.6.1.1

Medicine

Acyclovir*

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Tablet 200 mg

Tablet 400 mg

Tablet 800 mg

Powder for Injection 250 mg Powder for Injection 500 mg Oral liquid 400 mg/5 mL (p)

6.6.2 – Anti-cytomegalovirus (CMV) medicines

6.6.2.1

Medicine

Level of Healthcare

Valganciclovir**

S, T

Tablet 450 mg

Powder for oral solution 50 mg/mL

6.7- Medicines used in the Management of HIV

6.7.1 Nucleoside Reverse Transcriptase Inhibitors

6.7.1.1

Medicine

Abacavir

Level of Healthcare

S,T

*Acyclovir formulations are also listed in –

A. Section 6.7.5.1 – Anti-infective Medicines -Medicines used in the management of HIV – Medicines for treating Opportunistic Infections in People living with HIV

B. Section 21.1.1 – Ophthalmological Medicines- Anti-infective medicine

**Valganciclovir formulations are also listed in Section 6.7.5.5 – Anti-infective Medicines- Antiviral medicines -Medicines for treating Opportunistic Infections in People living with HIV

Dosage form(s) and strength(s)

Tablet 60 mg (p) Tablet 300 mg

6.7.1.2

6.7.1.3

6.7.1.6

6.7.1.7

6.7.1.8

6.7.1.9

Medicine

Abacavir (A) + Lamivudine (B)

Lamivudine

Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Dolutegravir (C)

Zidovudine

Level of Healthcare

S,T

P,S,T

Tablet 60mg(A)+30mg(B) (p)

Tablet 600 mg (A) + 300 mg (B)

S,T

Tablet 100 mg Tablet 150 mg

6.7.1.4

6.7.1.5

Tenofovir Disproxil Fumarate (TDF)*

Tenofovir Disproxil Fumarate (A) + Lamivudine (B)

S,T

Tablet 300 mg

Tablet 300 mg (A) + 300 mg (B)

Tablet 300 mg (A) + 300 mg (B) + 50 mg (C)

Tenofovir Disproxil Fumarate (A) + Lamivudine (B) + Efavirenz (C)

S,T

Tablet 300 mg (A) + 300 mg (B) + 600 mg (C)

S,T

Tablet 300 mg

Oral liquid 50 mg/5 mL (p)

Zidovudine (A) + Lamivudine (B)

S,T

Tablet 60 mg (A) + 30 mg (B) (p)

Tablet 300 mg (A) + 150 mg (B)

* Tenofovir Disproxil Fumarate formulations are also listed in Section 6.8.6 – Anti-infective Medicines Medicines used in Hepatitis B and Hepatitis C

Dosage form(s) and strength(s)

6.7.1.10

Medicine

Zidovudine (A) + Lamivudine (B) + Nevirapine (C)

Level of Healthcare

S,T

Tablet 60 mg (A) + 30 mg (B) + 50 mg (C) (p)

Tablet 300 mg (A) + 150 mg (B) + 200 mg (C)

6.7.2 Non-nucleoside Reverse Transcriptase Inhibitors

6.7.2.1

6.7.2.2

Medicine

Efavirenz

Level of Healthcare

S,T

Tablet 200 mg (p) Tablet 600 mg

Nevirapine

P,S,T

Tablet 200 mg

Dispersible Tablet 50 mg (p) Oral liquid 50 mg/ 5 mL (p)

Dosage form(s) and strength(s)

6.7.3 Integrase Inhibitors

6.7.3.1

Medicine

Dolutegravir

Level of Healthcare

S,T

Dosage form(s) and strength(s)

6.7.3.2

Raltegravir

S,T

Tablet 400 mg

6.7.4 Protease Inhibitors

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.7.4.1

Atazanavir (A) + Ritonavir (B)

S,T

Tablet 300 mg (A) + Tablet 100 mg (B)

Tablet 50 mg

6.7.4.2

6.7.4.3

6.7.4.4

6.7.4.5

Medicine

Darunavir

Darunavir (A) + Ritonavir (B)

Lopinavir (A) + Ritonavir (B)

Ritonavir

Level of Healthcare

S,T

Dosage form(s) and strength(s)

Tablet 600 mg

Tablet 600 mg (A) + Tablet 100 mg (B)

Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B)

Oral Liquid 80 mg (A) +

20 mg (B) /mL (p)

Capsule/ Sachet (containing pellets/granules) 40 mg (A) + 10 mg (B) (p)

Tablet 100 mg

Injection 250 mg Injection 1000 mg Tablet 300 mg

6.7.5 Medicines for treating Opportunistic Infections in People living with HIV

6.7.5.1

6.7.5.2

6.7.5.3

Medicine

Acyclovir*

Cefotaxime**

Clindamycin***

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

*Acyclovir formulations are also listed in –

A. Section 6.6.1.1 – Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines B. Section 21.1.1 – Ophthalmological Medicines- Anti-infective Medicine

** Cefotaxime formulations are also listed in Section 6.2.1.9 – Anti-infective Medicines – Antibacterials- Beta-Lactam medicines

***Clindamycin formulations are also listed in -A. Section 6.2.2.5 – Anti-infective Medicines – Antibacterials -Other antibacterials

B. Section 6.9.3.1 – Anti-infective Medicines – Medicines for amoebiasis and other parasitic infections – Antipneumocystosis and antitoxoplasmosis medicines

C. Section 6.10.1.5 – Anti-infective Medicines – Antimalarial medicines- For curative treatment

6.7.5.4

6.7.5.5

Medicine

Clotrimazole*

Valganciclovir**

Level of Healthcare

P,S,T

S,T

Dosage form(s) and strength(s)

6.7.6 Additional Medicines for Syndromic Management of Sexually Transmitted Infections

6.7.6.1

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

Azithromycin***

P,S,T

Tablet 1000 mg

Section 6.8 -Medicines used in Hepatitis B and Hepatitis C

6.8.1

6.8.2

Medicine

Daclatasvir

Level of Healthcare

Dosage form(s) and strength(s)

S,T

Tablet 30 mg Tablet 60 mg

Entecavir

S,T

Tablet 0.5 mg

Tablet 1 mg

Oral liquid 0.05 mg/mL (p)

*Clotrimazole formulations are also listed in –

A. Section 6.5.2 – Anti-infective Medicines -Antifungal medicines

B. Section 11.1.1 – Dermatological Medicines (Topical)- Antifungal medicines C. Section 16.3 – Ear, Nose and Throat Medicines

**Valganciclovir formulations are also listed in Section 6.6.2.1 – Anti-infective Medicines – Antiviral medicines -Anti Cytomegalovirus (CMV) medicines

***Azithromycin formulations are also listed in Section 6.2.2.1 – Anti-infective Medicines – Other antibacterials

Ointment 1 % Tablet/Capsule 450 mg

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.8.3

Ribavirin

S,T

Capsule 200 mg

6.8.4

Sofosbuvir

S,T

Tablet 400 mg

6.8.5

Tenofovir Alafenamide Fumarate (TAF)

S,T

Tablet 25 mg

6.8.6

Tenofovir Disproxil Fumarate (TDF)*

S,T

Tablet 300 mg

Section 6.9 -Antiprotozoal Medicines

6.9.1 – Medicines for Amoebiasis and other Parasitic Infections

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.9.1.1

Metronidazole**

P,S,T

Tablet 200 mg

Tablet 400 mg

Injection 500 mg/100 mL Oral liquid 200 mg/5 mL (p)

* Tenofovir Disproxil Fumarate formulations are also listed in Section 6.7.1.4 – Anti-infective Medicines Medicines used in the management of HIV- Nucleoside reverse transcriptase inhibitors

** Metronidazole formulations are also listed in Section 6.2.2.9 – Anti-infective Medicines – Antibacterials Beta-lactam medicines – Other antibacterials

6.9.2 – Antileishmaniasis Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.9.2.1

Amphotericin B*

S,T

a) Amphotericin B (conventional)- Injection 50 mg b) Lipid Amphotericin B- Injection 50 mg

c) Liposomal Amphotericin B- Injection 50 mg

6.9.2.2

Miltefosine

P,S,T

Capsule 50 mg

6.9.2.3

Paromomycin

P,S,T

Injection 375 mg/mL

6.9.3 – Antipneumocystosis and Antitoxoplasmosis Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.9.3.1

Clindamycin**

P,S,T

Capsule 150 mg Capsule 300 mg

*Amphotericin B formulations are also listed in Section 6.5.1 – Anti-infective Medicines- Antifungal medicines

**Clindamycin formulations are also listed in –

A. Section 6.2.2.5 – Anti-infective Medicines – Antibacterials -Other antibacterials

B. Section 6.7.5.3 – Anti-infective Medicines – Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV

C. Section 6.10.1.5 – Anti-infective Medicines- Antimalarial Medicines – For curative treatment

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.9.3.2

Co-trimoxazole* [Sulphamethoxazole (A) +

Trimethoprim (B)]

P,S,T

Tablet 400 mg (A) + 80 mg (B) Tablet 800 mg (A) + 160 mg (B) Oral liquid 200 mg (A) +

40 mg (B)/5 mL (p)

6.10-Antimalarial Medicines 6.10.1 – For curative treatment

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.10.1.1

Artemether (A) + Lumefantrine (B)

P,S,T

Tablet 20 mg (A) + 120 mg (B) Tablet 40 mg (A) + 240 mg (B) Tablet 80 mg (A) + 480 mg (B)

6.10.1.2

Artesunate

P,S,T

Powder for Injection 60 mg Powder for Injection 120 mg

6.10.1.3

Artesunate (A) + Sulphadoxine – Pyrimethamine (B)

P,S,T

Combi pack (A+B)

1 Tablet 25 mg (A) + 1 Tablet (250 mg + 12.5 mg) (B)

1 Tablet 50 mg (A) + 1 Tablet (500 mg + 25 mg) (B)

1 Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B)

1 Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B)

1 Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B)

*Co-trimoxazole formulations are also listed in Section 6.2.2.6 – Anti-infective Medicines- Antibacterials – Other antibacterials

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.10.1.4

Chloroquine

P,S,T

Tablet 150 mg

Oral liquid 50 mg/5 mL

6.10.1.5

Clindamycin*

P,S,T

Capsule 150 mg Capsule 300 mg

6.10.1.6

Primaquine

P,S,T

Tablet 2.5 mg Tablet 7.5 mg Tablet 15 mg

6.10.1.7

Quinine

P,S,T

Tablet 300 mg Injection 300 mg/mL

6.10.2 – For prophylaxis

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.10.2.1

Doxycycline**#

P,S,T

Capsule 100 mg

Oral liquid 50 mg/ 5mL

#for prophylaxis of P. vivax

6.10.2.2

Mefloquine#

Tablet 250 mg

#Only for use as chemoprophylaxis for long term travellers like military and travel troops, travelling from low endemic to high endemic area.

* Clindamycin formulations are also listed in –

A. Section 6.2.2.5 – Anti-infective Medicines – Antibacterials -Other antibacterials

B. Section 6.7.5.3 – Anti-infective Medicines – Antiviral medicines- Medicines for treating Opportunistic Infections in People living with HIV

C. Section 6.9.3.1 – Anti-infective Medicines – Antipneumocystosis and antitoxoplasmosis medicines

** Doxycycline formulations are also listed in Section 6.2.2.7 – Anti-infective Medicines- Antibacterials – Other antibacterials

Section 7

Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care

7.1 – Antineoplastic medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.1.1

5-Fluorouracil

Injection 250 mg/ 5 mL

7.1.2

6-Mercaptopurine

Tablet 50 mg

7.1.3

Actinomycin D

Powder for Injection 0.5 mg

7.1.4

All-trans retinoic acid

Capsule 10 mg

7.1.5

Arsenic trioxide

Injection 1mg/ mL

7.1.6

Bendamustine hydrochloride

Injection 25 mg/ vial Injection 100 mg/vial

7.1.7

Bleomycin

Powder for Injection 15 units

7.1.8

Bortezomib

Powder for Injection 2 mg

7.1.9

Calcium folinate

Tablet 15 mg Injection 3 mg/mL

7.1.10

Capecitabine

Tablet 500 mg

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.1.11

Carboplatin

Injection 10 mg/mL

7.1.12

Chlorambucil

Tablet 2 mg Tablet 5 mg

7.1.13

Cisplatin

Injection 1mg/mL

7.1.14

Cyclophosphamide

Tablet 50 mg

Powder for Injection 500 mg

7.1.15

Cytosine arabinoside

Injection 100 mg/vial Injection 500 mg/vial Injection 1000 mg/vial

7.1.16

Dacarbazine

Powder for Injection 200 mg Powder for Injection 500 mg

7.1.17

Daunorubicin

Injection 5 mg/mL

7.1.18

Docetaxel

Powder for Injection 20 mg Powder for Injection 80 mg

7.1.19

Doxorubicin

Injection 2 mg/mL

7.1.20

Etoposide

Capsule 50 mg Injection 20 mg/mL

7.1.21

Gefitinib

Tablet 250 mg

7.1.22

7.1.24

7.1.25

7.1.26

7.1.27

7.1.28

7.1.29

7.1.30

Medicine

Gemcitabine

Hydroxyurea*

L-Asparaginase

Melphalan

Methotrexate**

Level of Healthcare

Dosage form(s) and strength(s)

Powder for Injection 200 mg Powder for Injection 1000 mg

7.1.23

Capsule 500 mg

Ifosfamide

Imatinib

Powder for Injection 1000 mg Powder for Injection 2000 mg

Tablet 100 mg Tablet 400 mg

Irinotecan HCl trihydrate

Solution for injection 20 mg/ mL

Powder for Injection 5000 KU Powder for Injection 10000 KU

Lenalidomide

Capsule 5 mg Capsule 25 mg

S,T

Tablet 2.5 mg Tablet 5 mg

Tablet 10 mg Injection 50 mg/mL

*Hydroxyurea formulations are also listed in Section 8.1.6 – Medicines affecting Blood Antianaemia Medicines

**Methotrexate formulations are also listed in Section 2.4.3 – Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Disease Modifying Agents used in Rheumatoid Disorders

Tablet 2 mg Tablet 5 mg

7.1.36

7.1.38

Medicine

Thalidomide

Level of Healthcare

Dosage form(s) and strength(s)

7.1.31

Oxaliplatin

Injection 5 mg/mL in 10 mL vial

Injection 5 mg/mL in 20 mL vial

7.1.32

Paclitaxel

Injection 30 mg/5 mL Injection 100 mg/16.7 mL

7.1.33

Rituximab

Injection 10 mg/mL

7.1.34

7.1.35

Temozolomide

Capsule 20 mg Capsule 100 mg Capsule 250 mg

Capsule 50 mg Capsule 100 mg

Trastuzumab

Vinblastine

Vincristine

Injection 440 mg/50 mL

7.1.37

Injection 1 mg/mL

7.2-Hormones and Anti-hormones used in Cancer Therapy

7.2.1

Medicine

Bicalutamide

Level of Healthcare

Tablet 50 mg

7.2.2

Letrozole

Tablet 2.5 mg

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.2.3

Leuprolide acetate

Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg

7.2.4

Prednisolone*

S,T

Tablet 10 mg

Tablet 20 mg

Tablet 40 mg

Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p) Injection 20 mg/2 mL

7.2.5

Tamoxifen

Tablet 10 mg Tablet 20 mg

7.3 – Immunosuppressive Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.3.1

Azathioprine**

Tablet 50 mg

7.3.2

Cyclosporine

Capsule 25 mg

Capsule 50 mg

Capsule 100 mg

Oral liquid 100 mg/mL (p) Injection 50 mg/mL

*Prednisolone formulations are also listed in –

A. Section 3.6 – Antiallergics and Medicines used in Anaphylaxis

B. Section 18.1.5 – Hormones, other Endocrine Medicines and Contraceptives -Adrenal Hormones and synthetic substitutes

C. Section 21.2.1 – Ophthalmological Medicines – Antiinflammatory Medicine

**Azathioprine formulations are also listed in Section 2.4.1 – Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Disease Modifying Agents used in Rheumatoid Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.3.3

Mycophenolate mofetil

Tablet 250 mg Tablet 500 mg

7.3.4

Tacrolimus

Capsule 0.5 mg Capsule 1 mg Capsule 2 mg

7.4-Medicines used in Palliative Care

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.4.1

Allopurinol*

S,T

Tablet 100 mg

7.4.2

Amitriptyline**

S,T

Tablet 10 mg Tablet 25 mg

7.4.3

Dexamethasone***

S,T

Tablet 0.5 mg Tablet 4 mg Injection 4 mg/mL

*Allopurinol formulations are also listed in Section 2.3.1 – Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs),Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Medicines used to treat Gout

**Amitriptyline formulations are also listed in A. Section 5.2.5 – Medicines used in Neurological Disorders – Anti-migraine medicines –

For prophylaxis

B. Section 23.2.1.1 – Medicines in treatment of Psychiatric Disorders -Medicines used in mood disorders- Medicines used in depressive disorders

***Dexamethasone formulations are also listed in

A. Section 3.4 – Antiallergics and medicines used in anaphylaxis

B. Section 18.1.1 – Hormones, other Endocrine Medicines and Contraceptives – Adrenal hormones and synthetic substitutes

C. Section 27.1 – Medicines for COVID 19 management

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.4.4

Diazepam*

S,T

Tablet 2 mg Tablet 5 mg Injection 5 mg/mL

7.4.5

Filgrastim

Injection 300 mcg

7.4.6

Fluoxetine**

S,T

Capsule 20 mg

7.4.7

Haloperidol***

S,T

Tablet 1.5 mg Tablet 5 mg Injection 5 mg/mL

7.4.8

Lactulose****

S,T

Oral liquid 10 g/15 mL

7.4.9

Loperamide

S,T

Tablet 2 mg

*Diazepam formulations are also listed Section 5.1.3 – Medicines used in Neurological Disorders – Anticonvulsants/Antiepileptics

**Fluoxetine formulations are also listed in

A. Section 23.2.1.3 – Medicines in used in treatment of Psychiatric Disorders – Medicines used in mood disorders – Medicines used in depressive disorders

B. Section 23.4.2 – Medicines used in treatment of Psychiatric Disorders – Medicines used in obsessive compulsive disorders and panic attacks

***Haloperidol formulations are also listed in Section 23.1.3 –

Medicines used in treatment of psychiatric Disorders – Medicines used in psychotic disorders

****Lactulose formulations are also listed in Section 17.5.3 – Gastrointestinal Medicines – Laxatives

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.4.10

Metoclopramide*

S,T

Tablet 10 mg

Oral liquid 5 mg/5 mL (p) Injection 5 mg/mL

7.4.11

Mesna

Injection 100 mg/mL

7.4.12

Midazolam**

S,T

Injection 1 mg/mL

7.4.13

Morphine***

S,T

Tablet 10 mg

Modified Release Tablet 30 mg

7.4.14

Ondansetron****

S,T

Tablet 4 mg

Tablet 8 mg

Oral liquid 2 mg/5 mL (p) Injection 2 mg/mL

*Metoclopramide formulations are also listed in Section 17.2.2 – Gastrointestinal Medicines Antiemetics

**Midazolam formulations are also listed in –

A. Section 1.3.3 – Medicines used in Anaesthesia – Preoperative medication and sedation for short term procedures

B. Section 5.1.7 – Medicines used in Neurological Disorders -Anticonvulsants/Antiepileptics

***Morphine formulations are also listed in –

A. Section 1.3.4 – Medicines used in Anaesthesia – Preoperative medication and sedation for short term procedures

B. Section 2.2.2 – Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Opioid Analgesics

****Ondansetron formulations are also listed Section 17.2.3 – Gastrointestinal Medicines anti-ulcer medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.4.15

Tramadol*

S,T

Capsule 50 mg Capsule 100 mg Injection 50 mg/mL

7.4.16

Zoledronic acid

Powder for Injection 4 mg

Section 8 Medicines affecting Blood

8.1- Antianaemia Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

8.1.1

Erythropoietin

S,T

Injection 2000 IU/mL Injection 10000 IU/mL

8.1.2

Ferrous salts

(a) Iron Dextran (b) Iron sorbitol citrate complex

P,S,T

Tablet equivalent to 60 mg of elemental iron

Injection 50 mg/mL

8.1.3

Ferrous Salt (A)+ Folic acid (B)

P,S,T

Tablet 45 mg elemental iron (A) + 400 mcg (B)

Tablet 100 mg elemental iron (A) + 500 mcg (B)

Oral liquid 20 mg elemental iron (A) + 100 mcg/mL (B) (p)

*Tramadol formulations are also listed in Section 2.2.3 – Analgesics, Antipyretics, Non- steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Opioid Analgesics

8.1.5

8.1.6

8.1.7

Medicine

Hydroxocobalamin

Hydroxyurea*

Iron sucrose

Level of Healthcare

P,S,T

S,T

Dosage form(s) and strength(s)

8.1.4

Folic Acid

P,S,T

Tablet 1 mg Tablet 5 mg

8.2 – Medicines affecting Coagulation

Injection 1 mg/mL Capsule 500 mg Injection 20 mg/mL

Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL

8.2.1

Medicine

Enoxaparin**

Level of Healthcare

S,T

Dosage form(s) and strength(s)

8.2.2

Heparin***

S,T

Injection 1000 IU/mL Injection 5000 IU/mL

8.2.3

Phytomenadione (Vitamin K1)

P,S,T

Tablet 10 mg Injection 10 mg/mL

8.2.4

8.2.5

Protamine Sulphate

Tranexamic acid

S,T

P,S,T

Injection 10 mg/mL

Tablet 500 mg Injection 100 mg/mL

* Hydroxyurea formulations are also listed in Section 7.1.26 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Antineoplastic medicines

** Enoxaparin formulations are also listed in

A. Section 10.5.4 – Cardiovascular Medicines – Antiplatelet and Antithrombotic Medicines B. Section 27.2 – Medicines for COVID 19 management

*** Heparin formulations are also listed in Section 10.5.5 – Cardiovascular Medicines – Antiplatelet and Antithrombotic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

8.2.6

Warfarin

S,T

Tablet 1 mg Tablet 2 mg Tablet 3 mg Tablet 5 mg

Section 9

Blood products and Plasma substitutes

9.1 – Blood and Blood components

All forms of the following as approved by licensing authority are considered as included in NLEM. However, considering the process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

9.1.1

Fresh frozen plasma

S,T

As licensed

9.1.2

Platelet rich plasma/ Platelet concentrates

S,T

As licensed

9.1.3

Red blood cells/ Packed RBCs

S,T

As licensed

9.1.4

Whole blood

S,T

As licensed

9.2 – Plasma substitutes

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

9.2.1

Dextran-40

S,T

Injection 10 %

9.3 – Plasma fractions for specific use

In case of coagulation factors and other blood products, irrespective of variation in source, all forms of these products as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, they should be considered differently for purposes such as procurement policy, pricing etc.

9.3.1

9.3.2

Medicine

Coagulation factor IX

Coagulation factor VIII

Level of Healthcare

S,T

Powder for Injection 600 IU

Powder for Injection 250 IU Powder for Injection 500 IU

9.3.3

Cryoprecipitate

S,T

As licensed

Dosage form(s) and strength(s)

10.1-Medicines used in Angina

Section 10 Cardiovascular Medicines

10.1.1

Medicine

Diltiazem

Level of Healthcare

P,S,T

Tablet 30 mg

Tablet 60 mg

Modified Release Tablet 180 mg

S, T

Injection 5 mg/mL

10.1.2

10.1.4

Glyceryl trinitrate

Isosorbide dinitrate

Metoprolol

P,S,T

Sublingual Tablet 0.5 mg

S,T

Injection 5 mg/mL

10.1.3

Tablet 5 mg Tablet 10 mg

P,S,T

Tablet 25 mg

Tablet 50 mg

Tablet 100 mg

Modified Release Tablet 100 mg

S,T

Injection 1 mg/mL

Dosage form(s) and strength(s)

10.2 – Antiarrhythmic medicines

10.2.1

10.2.2

10.2.4

10.2.5

Medicine

Adenosine

Amiodarone

Digoxin*

Lignocaine**

Verapamil

Level of Healthcare

S,T

Dosage form(s) and strength(s)

Tablet 100 mg Tablet 200 mg Injection 50 mg/mL

10.2.3

S,T

Tablet 0.25 mg

Oral liquid 0.05 mg/mL Injection 0.25 mg/mL

Esmolol

S,T

Injection 10 mg/mL

Injection 2%

10.2.6

S,T

Tablet 40 mg

Tablet 80 mg Injection 2.5 mg/ mL

10.3 – Antihypertensive Medicines

Medicine

Amlodipine

Level of Healthcare

Dosage form(s) and strength(s)

10.3.1

P,S,T

Tablet 2.5 mg Tablet 5 mg Tablet 10 mg

*Digoxin formulations are also listed in Section 10.4.1 – Cardiovascular Medicines – Medicines used in Shock and Heart Failure

**Lignocaine formulations are also listed in Section 1.2.2 – Medicines used in Anaesthesia – Local Anaesthetics

Injection 3 mg/mL

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.3.2

Enalapril

P,S,T

Tablet 2.5 mg Tablet 5 mg

10.3.3

Hydrochlorothiazide *

P,S,T

Tablet 12.5 mg Tablet 25 mg

10.3.4

Labetalol

P,S,T

Tablet 50 mg Tablet 100 mg

P,S,T

Injection 5 mg/mL

10.3.5

Ramipril

P,S,T

Tablet 2.5 mg Tablet 5 mg

10.3.6

Sodium nitroprusside

S, T

Injection 10 mg/mL

10.3.7

Telmisartan

P,S,T

Tablet 20 mg Tablet 40 mg Tablet 80 mg

10.4 – Medicines used in Shock and Heart failure

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.4.1

Digoxin**

S,T

Tablet 0.25 mg

Oral liquid 0.05 mg/mL Injection 0.25 mg/mL

*Hydrochlorothiazide formulations are also listed in Section 15.2 – Diuretics

**Digoxin formulations are also listed in Section 10.2.3 – Cardiovascular Medicines – Antiarrhythmic medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.4.2

Dobutamine

S,T

Injection 50 mg/mL

10.4.3

Dopamine

S,T

Injection 40 mg/mL

10.4.4

Noradrenaline

S,T

Injection 2 mg/mL

10.4.5

Spironolactone*

P,S,T

Tablet 25 mg Tablet 50 mg

10.5- Antiplatelet and Antithrombotic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.5.1

Acetylsalicylic acid**

P,S,T

Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 150 mg Conventional/Effervescent/ Dispersible/ Enteric coated Tablets 325 mg

Enteric coated Tablet 75 mg Enteric coated Tablet 100 mg

*Spironolactone formulations are also listed in Section 15.4 – Diuretics

**Acetylsalicyclic acid formulations are also listed in –

A. Section 2.1.1 – Analgesics, Antipyretics, Non-steroidal Anti-inflammatory

Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders – Non-opioid Analgesics, Antipyretics and Non-steroidal Anti- inflammatory Drugs

B. Section 5.2.1 – Medicines used in Neurological Disorders- Antimigraine medicines

10.5.2

Clopidogrel

P,S,T

Tablet 75 mg Tablet 150 mg

10.5.3

Dabigatran

S, T

Tablet 110 mg Tablet 150 mg

10.5.4

Enoxaparin*

S,T

Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL

10.5.5

Heparin**

S,T

Injection 1000 IU/mL Injection 5000 IU/mL

10.5.6

Streptokinase

S,T

Injection 750,000 IU Injection 15,00,000 IU

10.5.7

Tenecteplase

S,T

Injection 30 mg/vial Injection 40 mg/vial

10.6 – Hypolipidemic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.6.1

Atorvastatin

P,S,T

Tablet 10 mg Tablet 20 mg Tablet 40 mg Tablet 80 mg

*Enoxaparin formulations are also listed in –

A. Section 8.2.1 – Medicines affecting Blood – Medicines affecting coagulation B. Section 27.2 – Medicines for COVID 19 management

**Heparin formulations are also listed in Section 8.2.2 – Medicines affecting Blood – Medicines affecting coagulation

Section 11 Dermatological Medicines (Topical)

11.1 – Antifungal Medicines

11.1.1

Medicine

Clotrimazole*

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Cream 1 % Lotion 1 %

11.2 – Antibacterial Medicines

11.2.2

Medicine

Framycetin

Fusidic acid

Level of Healthcare

11.2.1

P,S,T

Cream 1 %

P,S,T

Cream 2 %

11.2.3

11.3.1

Silver sulphadiazine

Medicine

P,S,T

Cream 1 %

11.3-Antiinflammatory and Antipruritic Medicines

Level of Healthcare

Dosage form(s) and strength(s)

Betamethasone valerate

P,S,T

Cream 0.05 % Cream 0.1 %

*Clotrimazole formulations are also listed in –

A. Section 6.5.2 – Anti-infective Medicines -Antifungal medicines

B. Section 6.7.5.4 – Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV

C. Section 16.3 – Ear, Nose and ThroatMedicines

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

11.3.2

Calamine

P,S,T

Lotion (As per IP)

11.4 – Keratolytic agents

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

11.4.1

Benzoyl peroxide

P,S,T

Gel 2.5 % – 5 %

11.4.2

Coal tar (A) + Salicylic Acid (B)

P,S,T

Solution 1 % (A) + 3 % (B)

11.4.3

Podophyllin resin

S,T

Solution 20 %

11.4.4

Salicylic acid

P,S,T

Ointment 3-6 %

11.5 – Scabicides and Pediculicides

11.6 Miscellaneous

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

11.5.1

Permethrin

P,S,T

Lotion 1 % Cream 5 %

Medicine

Level of Healthcare

11.6.1

Glycerin/glycerol (as mentioned in IP)

P,S,T

Topical

Dosage form(s) and strength(s)

Section 12 Diagnostic agents

12.1 – Ophthalmic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

12.1.1

Fluorescein

S,T

Ophthalmic Strips

12.1.2

Proparacaine*

S,T

Eye Drops 0.5%

12.1.3

Tropicamide**

S,T

Eye drop 1 %

12.2 – Radiocontrast Media

12.2.1

Barium sulphate

S,T

Oral Liquid 95% w/v

12.2.2

Gadobenate dimeglumine

Injection 529 mg/mL

12.2.3

Iohexol

S,T

Injection 140 to 350 mg iodine/mL

12.2.4

Meglumine diatrizoate

S,T

Injection 60 % w/v Injection 76 % w/v

* Proparacaine formulations are also listed in Section 21.3.1 – Ophthalmological Medicines- Local Anaesthetics

** Tropicamide formulations are also listed in Section 21.5.4 – Ophthalmological Medicines Mydriatics

13.1

13.2

Section 13

Dialysis components (Haemodialysis and Peritoneal Dialysis)

Medicine

Haemodialysis fluid

Peritoneal dialysis solution

Level of Healthcare

S,T

As licensed

S,T

As licensed

Section 14 Antiseptics and Disinfectants

Dosage form(s) and strength(s)

14.1 Antiseptics

14.1.1

14.1.2

14.1.4

14.1.5

Medicine

Chlorhexidine

Ethyl alcohol (Denatured)

Hydrogen peroxide

Level of Healthcare

P,S,T

Solution 5% (Concentrate)

Solution 70%

14.1.3

P,S,T

Solution 6 %

Methylrosanilinium chloride

(Gentian Violet)

Povidone iodine*

P,S,T

Topical preparation 0.25% to 2%

Solution 4 % to 10 %

*Povidone Iodine formulations are also listed in Section 21.1.5 – Ophthalmological Medicines – Anti-infective medicine

Dosage form(s) and strength(s)

14.2 Disinfectants

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

14.2.1

Glutaraldehyde

S,T

As Licensed

14.2.2

Potassium permanganate

P,S,T

Crystals for topical solution

Section 15 Diuretics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

15.1

Furosemide

P,S,T

Tablet 40 mg

Oral liquid 10 mg/mL Injection 10 mg/ mL

15.2

Hydrochlorothiazide *

P,S,T

Tablet 25 mg Tablet 50 mg

15.3

Mannitol

P,S,T

Injection 10 % Injection 20 %

15.4

Spironolactone**

P,S,T

Tablet 25 mg Tablet 50 mg

* Hydrochlorothiazide formulations are also listed in Section 10.3.3 – Antihypertensive Medicines

**Spironolactone formulations are also listed in Section 10.4.5 – Cardiovascular Medicines – Medicines used in shock and heart failure

Section 16

Ear, Nose and Throat Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

16.1

Budesonide*

P,S,T

Nasal Spray 50 mcg/dose Nasal Spray 100 mcg/dose

16.2

Ciprofloxacin**

P,S,T

Drops 0.3 %

16.3

Clotrimazole***

P,S,T

Drops 1 %

16.4

Xylometazoline

P,S,T

Nasal drops 0.05 % Nasal drops 0.1 %

*Budesonide formulations are also listed in Section 24.1 – Medicines acting on the respiratory tract – Antiasthmatic Medicines

**Ciprofloxacin formulations are also listed in

A. Section 6.2.2.3 – Anti-infective Medicines- Antibacterials -Other Antibacterials B. Section 21.1.2 – Ophthalmological Medicines- Anti-infective Medicines

***Clotrimazole formulations are also listed in –

A. Section 6.5.2 – Anti-infective Medicines -Antifungal medicines

B. Section 6.7.5.4 – Anti-infective Medicines Antiviral medicines- Medicines used in the management of HIV

C. Section 11.1.1 – Dermatological Medicines (Topical) -Antifungal medicines

Section 17 Gastrointestinal Medicines

17.1 – Antiulcer Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

17.1.1

Omeprazole

P,S,T

Capsule 10 mg

Capsule 20 mg

Capsule 40 mg

Powder for oral liquid 20 mg

17.1.2

Pantoprazole

S,T

Injection 40 mg

17.2 Antiemetics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

17.2.1

Domperidone

P,S,T

Tablet 10 mg

Oral Liquid 1 mg/mL

17.2.2

Metoclopramide*

P,S,T

Tablet 10 mg Injection 5 mg/mL

17.2.3

Ondansetron*

S,T

Tablet 4 mg

Oral Liquid 2 mg/5 mL (p) Injection 2 mg/ mL

*Metoclopramide formulations are also listed in Section 7.4.10 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care

*Ondansetron formulations are also listed in Section 7.4.14 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Medicines used in Palliative Care

17.3 Anti-inflammatory medicines

17.4.2

17.5.1

Medicine

Dicyclomine

Hyoscine butyl bromide

Medicine

Level of Healthcare

S, T

P,S,T

Dosage form(s) and strength(s)

17.3.1

5-aminosalicylic acid (Mesalazine/ Mesalaine)

Tablet 400 mg Suppository 500 mg Retention Enema

17.4 Antispasmodic medicines

17.4.1

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

Tablet 10 mg

Oral Solution 10 mg/5mL Injection 10 mg/ mL

P,S,T

Tablet 100 mg Injection 20 mg/ mL

17.5 Laxatives

Level of Healthcare

Bisacodyl

P,S,T

Tablet 5 mg Suppository 5 mg

17.5.2

Ispaghula

P,S,T

Granules/ Husk/ Powder

Dosage form(s) and strength(s)

17.5.3

17.6.2

Medicine

Lactulose*

Zinc Sulphate

Level of Healthcare

S,T

P,S,T

Dosage form(s) and strength(s)

Oral Liquid 10 g/15 mL

17.6 Medicines used in diarrhea

17.6.1

Medicine

Oral rehydration salts**

Level of Healthcare

Dosage form(s) and strength(s)

As licensed

P,S,T

Dispersible Tablet 20 mg

17.7 Other medicines

17.7.1

Medicine

Somatostatin

Level of Healthcare

Powder for Injection 3 mg

*Lactulose formulations are also listed in Section 7.4.8 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Medicines used in Palliative Care

**Oral rehydration salts formulations are also listed in Section 25.3 – Solutions correcting water, electrolyte disturbances and acid-base disturbances

Dosage form(s) and strength(s)

Section 18

Hormones, other Endocrine Medicines and Contraceptives

18.1-Adrenal Hormones and Synthetic substitutes

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.1.1

Dexamethasone*

S,T

Tablet 0.5 mg Injection 4 mg/mL

18.1.2

Fludrocortisone

S,T

Tablet 0.1 mg

18.1.3

Hydrocortisone**

P,S,T

Tablet 5 mg

Tablet 10 mg

Tablet 20 mg

Powder for Injection 100 mg

18.1.4

Methylprednisolone ***

S,T

Injection 40mg/mL

*Dexamethasone formulations are also listed in –

A. Section 3.4 – Antiallergics and Medicines used in Anaphylaxis

B. Section 7.4.3 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care – Medicines used in Palliative Care

C. Section 27.1 – Medicines for COVID 19 Management

** Hydrocortisone formulations are also listed in Section 3.5 – Antiallergics and Medicines

used in Anaphylaxis

*** Methylprednisolone formulations are also listed in section 27.3- Medicines for COVID – 19 management

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.1.5

Prednisolone*

P,S,T

Tablet 5 mg

Tablet 10 mg

Tablet 20 mg

Oral liquid 5 mg/5 mL (p) Oral liquid 15 mg/5 mL (p)

18.2 Contraceptives

18.2.1 – Hormonal Contraceptives

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.2.1.1

Ethinylestradiol (A)+ Levonorgestrel (B)

P,S,T

Tablet 0.03 mg (A) + Tablet 0.15 mg (B)

18.2.1.2

Levonorgestrel

P,S,T

Tablet 0.75 mg Tablet 1.5 mg

18.2.1.3

Ormeloxifene (Centchroman)

P,S,T

Tablet 30 mg

*Prednisolone formulations are also listed in –

A. Section 3.7 – Antiallergics and Medicines used in Anaphylaxis

B. Section 7.2.4 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti- hormones used in cancer therapy

C. Section 21.2.1 – Ophthalmological Medicines – Antiinflammatory medicine

18.2.2 – Intrauterine Devices

18.2.2.2

18.2.3.1

Medicine

Condom

Level of Healthcare

18.2.2.1

Hormone releasing IUD

IUD containing Copper

P,S,T

Contains 52 mg of Levonorgestrel

As licensed

18.2.3 – Barrier methods

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

As Licensed as per the standards of Drugs Rules, 1945

Dosage form(s) and strength(s)

18.3 – Medicines used in Diabetes Mellitus

18.3.1 – Insulins and other Antidiabetic agents

18.3.1.1

Medicine

Level of Healthcare

Glimepiride

P,S,T

Tablet 1 mg Tablet 2 mg

18.3.1.2

Insulin (Soluble)

P,S,T

Injection 40 IU/mL

18.3.1.3

Insulin Intermediate Acting (NPH)

P,S,T

Injection 40 IU/mL

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.3.1.4

Insulin Glargine

P,S,T

Injection 100 IU/mL

18.3.1.5

Insulin Premix Injection 30:70 (Regular : NPH)

P,S,T

Injection 40 IU/mL

18.3.1.6

Metformin

P,S,T

Tablet 500 mg

Tablet 1000 mg

Modified release Tablet 1000 mg

18.3.1.7

Teneligliptin

P,S,T

Tablet 20 mg

18.3.2 – Medicines used to treat Hypoglycemia

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.3.2.1

Glucose*

P,S,T

Injection 25 %

18.4-Ovulation Inducers

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.4.1

Clomiphene citrate

Tablet 50 mg Tablet 100 mg

18.4.2

Human chorionic gonadotropin

S,T

Injection 2000 IU Injection 5000 IU Injection 10000 IU

*Glucose formulations are also listed in Section 25.1 – Solutions correcting water, electrolyte disturbances and acid-base disturbances

18.5-Progestogens

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.5.1

Medroxyprogesterone acetate

P,S,T

Tablet 5 mg

Tablet 10 mg Injection 150 mg/ mL

18.5.2

Norethisterone

P,S,T

Tablet 5 mg

18.6-Thyroid and Antithyroid Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.6.1

Carbimazole

P,S,T

Tablet 5 mg Tablet 10 mg Tablet 20 mg

18.6.2

Levothyroxine

P,S,T

Tablet 12.5 mcg to 150 mcg*

(*Several strengths are available in market such as 12.5,25,50,62.5, 75, 88,100, 112mcg. Therefore, it was considered to give a range of available strengths)

Section 19 Immunologicals

In case of these biologicals, irrespective of variation in source, composition and strengths, all the products of the same vaccine/ sera/ immunoglobulin, as approved by licensing authority are considered as included in NLEM. However, considering the source, process, technology and other relevant aspects, different products of the same biological should be considered differently for purposes such as procurement policy, pricing etc.

19.1-Diagnostic agents

19.1.1

19.2.2

19.2.3

19.2.4

19.2.5

Medicine

Tuberculin, Purified Protein derivative

Anti-D immunoglobulin

Diphtheria antitoxin

Hepatitis B immunoglobulin

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

P,S,T

As Licensed

19.2-Sera and Immunoglobulins (Liquid/ Lyophilized)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

19.2.1

Anti-rabies immunoglobulin

Anti-tetanus immunoglobulin

P,S,T

As Licensed

S,T

P,S,T

As Licensed

S,T

As Licensed

19.2.6

19.2.7

Human normal immunoglobulin

As Licensed

Snake Venom Antiserum*

P,S,T

a) Soluble/ liquid polyvalent – As Licensed

b) Lyophilized polyvalent – As Licensed

*Snake Venom antiserum also listed in Section 4.2.12 – Antidotes and Other Substances used in Management of Poisonings/Envenomation Specific

As Licensed

19.3-Vaccines

a) All the vaccines which are under Universal Immunization Program of India (UIP) will be deemed included in NLEM. Presently, the UIP has BCG, DPT, OPV, measles, Hepatitis B, Japanese encephalitis, Pentavalent Vaccines and Rota virus vaccine.

b) The vaccines, which have been approved by National Technical Advisory Group on Immunization (NTAGI) and planned to be given under UIP, will be deemed to be included as and when listed in UIP. These vaccines are inactivated polio vaccine (IPV) and Measles Rubella (MR).

c) In future, the vaccines which are under consideration, if and when included in UIP, will also be deemed included from the date of inclusion in UIP. These are pneumococcal and HPV vaccines.

For Universal Immunization

19.3.1

19.3.2

Medicine

BCG vaccine

DPT+ Hib+ Hep B vaccine

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

As licensed

P,S,T

As licensed

19.3.3

19.3.4

DPT vaccine

Hepatitis B vaccine

P,S,T

As licensed

19.3.5

Japanese encephalitis vaccine

P,S,T

As licensed

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

19.3.6

Measles vaccine

P,S,T

As licensed

19.3.7

Oral poliomyelitis vaccine

P,S,T

As licensed

19.3.8

Rotavirus vaccine

P,S,T

As licensed

19.3.9

Tetanus toxoid

P,S,T

As licensed

19.4 – For Specific Group of Individuals

20.1

Medicine

Rabies vaccine

Medicine

Alprostadil

Caffeine

Level of Healthcare

S,T

Dosage form(s) and strength(s)

19.4.1

P,S,T

As licensed

Section 20 Medicines for Neonatal Care

Level of Healthcare

Dosage form(s) and strength(s)

20.2

S,T

Oral liquid 20 mg/mL Injection 20 mg/mL

20.3

Surfactant

S,T

Suspension for intratracheal instillation (As licensed)

Injection 0.5 mg/mL

Section 21 Ophthalmological Medicines

21.1-Anti-infective Medicines

21.1.1

21.1.4

Medicine

Acyclovir*

Ciprofloxacin**

Natamycin

Povidone iodine***

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

21.1.2

Drops 0.3% Ointment 0.3%

21.1.3

P,S,T

Drops 5 %

Ointment 3%

Drops 5 %

21.2-Antiinflammatory Medicine

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

21.2.1

Prednisolone****

P,S,T

Drops 1 %

*Acyclovir formulations are also listed in –

A. Anti-infective Medicines -Antiviral medicines -Anti-herpes medicines Section 6.6.1.1 B. Anti-infective Medicines -Medicines used in the management of HIV -Medicines for treating Opportunistic Infections in People living with HIV Section 6.7.5.1

**Ciprofloxacin formulations are also listed in –

A. Section 6.2.2.3 – Anti-infective Medicines- Antibacterials – Other Antibacterials B. Section 16.2 Ear, Nose and Throat Medicines

***Povidone Iodine Also listed in Section 14.1.5 – Antiseptics and Disinfectants- Antiseptics

****Prednisolone formulations are also listed in –

A. Section 3.7 – Antiallergics and Medicines used in Anaphylaxis

B. Section 7.2.4 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care Hormones and anti-hormones used in cancer therapy

C. Section 18.1.5 – Hormones, other Endocrine Medicines and Contraceptives- Adrenal Hormones and synthetic substitutes

21.3- Local Anaesthetic

21.4.1

21.4.2

21.4.3

21.4.4

Medicine

Proparacaine*

21.4-Miotics and Antiglaucoma Medicines

Medicine

Level of Healthcare

21.3.1

P,S,T

Drops 0.5 %

Level of Healthcare

Dosage form(s) and strength(s)

Acetazolamide

Latanoprost

P,S,T

Tablet 250 mg

P,S,T

Drops 0.005 %

Pilocarpine

P,S,T

Drops 2 % Drops 4 %

Timolol

P,S,T

Drops 0.25 % Drops 0.5 %

Dosage form(s) and strength(s)

21.5-Mydriatics

21.5.1

Medicine

Atropine**

Level of Healthcare

P,S,T

Drops 1% Ointment 1%

*Proparacaine formulations are also listed in listed in Section 12.1.2 – Diagnostic agents- Ophthalmic Medicines

**Atropine formulations are also listed in –

A. Section 1.3.1 – Medicines used in Anaesthesia -Preoperative medication and sedation for short term procedures

B. Section 4.2.1 – Antidotes and Other substances used in Management of poisoning/Envenomation – specific

Dosage form(s) and strength(s)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

21.5.2

Homatropine

P,S,T

Drops 2%

21.5.3

Phenylephrine

P,S,T

Drops 5 % Drops 10 %

21.5.4

Tropicamide*

P,S,T

Drops 1 %

21.6-Miscellaneous

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

21.6.1

Carboxymethyl cellulose

P,S,T

Drops 0.5% Drops 1%

21.6.2

Hydroxypropyl methylcellulose

Injection 2%

Section 22 Oxytocics and Antioxytocics

22.1 – Oxytocics and Abortifacient

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

22.1.1

Dinoprostone

S,T

Tablet 0.5 mg Gel 0.5 mg

22.1.2

Methylergometrine

P,S,T

Tablet 0.125 mg Injection 0.2 mg/mL

*Tropicamide formulations are also listed in Section 12.1.3 – Diagnostic agents – Ophthalmic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

22.1.3

Mifepristone

P,S,T

Tablet 200 mg

22.1.4

Misoprostol

P,S,T

Tablet 100 mcg Tablet 200 mcg

22.1.5

Oxytocin

P,S,T

Injection 5 IU/mL Injection 10 IU/mL

22.2 – Medicines used in Preterm Labour

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

22.2.1

Betamethasone

P,S,T

Injection 4 mg/mL

22.2.2

Nifedipine

S,T

Tablet 10 mg

Section 23

Medicines used in treatment of Psychiatric Disorders

23.1 – Medicines used in Psychotic Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.1.1

Clozapine

Tablet 25 mg Tablet 50 mg Tablet 100 mg

23.1.2

Fluphenazine

P,S,T

Injection 25 mg/mL

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.1.3

Haloperidol*

S,T

Tablet 2 mg

Tablet 5 mg

Tablet 10 mg

Tablet 20 mg

Oral liquid 2 mg/5 mL Injection 5 mg/mL

23.1.4

Risperidone

P,S,T

Tablet 1 mg

Tablet 2 mg

Tablet 4 mg

Oral liquid 1 mg/mL

Injection (Long acting) 25 mg Injection (Long acting) 37.5 mg

23.2 – Medicines used in Mood Disorders

23.2.1 – Medicines used in Depressive Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.2.1.1

Amitriptyline**

P,S,T

Tablet 10 mg Tablet 25 mg Tablet 50 mg Tablet 75 mg

*Haloperidol formulations are also listed in Section 7.4.7 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

**Amitriptyline formulations are also listed in –

A. Section 5.2.5 – Medicines used in Neurological Disorders – Anti-migraine medicines- For prophylaxis

B. Section 7.4.2 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.2.1.2

Escitalopram

P,S,T

Tablet 5 mg Tablet 10 mg Tablet 20 mg

23.2.1.3

Fluoxetine*

P,S,T

Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg

23.2.2 – Medicines used in Bipolar Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.2.2.1

Lithium

S,T

Tablet 300 mg

23.2.2.2

Sodium valproate**

P,S,T

Tablet 200 mg Tablet 300 mg Tablet 500 mg Modified Release – Tablet 300 mg Tablet 500 mg

23.2.2.3

Carbamazepine***

P,S,T

Tablet 100 mg

Tablet 200 mg

Tablet 400 mg

Modified Release –

Tablet 200 mg

Tablet 400 mg

Oral liquid 100 mg/5 mL (p)

*Fluoxetine formulations are also listed in –

A. Section 7.4.6 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

B. Section 7.4.6 – Medicines used in treatment of psychiatric Disorders – Medicines used in obsessive compulsive disorders and panic attacks

** Sodium Valproate formulations are also listed in Section 5.1.10 – Medicines used in Neurological Disorders -Anticonvulsants /antiepileptics

***Carbamazepine formulations are also listed in Section 5.1.1 – Medicines used in Neurological Disorders- Anticonvulsants/antiepileptics

23.3 – Medicines used in Generalized Anxiety and Sleep Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.3.1

Clonazepam

P,S,T

Tablet 0.25 mg Tablet 0.5 mg Tablet 1 mg

23.3.2

Zolpidem

P,S,T

Tablet 5 mg Tablet 10 mg

23.4 – Medicines used in Obsessive Compulsive Disorders and Panic attacks

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.4.1

Clomipramine

P,S,T

Capsule 10 mg Capsule 25 mg Capsule 75 mg

23.4.2

Fluoxetine*

S,T

Capsule 10 mg Capsule 20 mg Capsule 40 mg Capsule 60 mg

*Fluoxetine formulations are also listed in –

A. Section 7.4.6 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

B. Section 23.2.1.3 Medicines used in treatment of Psychiatric Disorders – Medicines used in mood disorders – Medicines used in depressive disorders

23.5 Medicines used in Disorders due to Psychoactive substance abuse

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.5.1

Buprenorphine

P,S,T

Tablet (Sub-lingual) 0.4 mg

23.5.2

Buprenorphine (A) + Naloxone (B)

P,S,T

Tablet (Sub-lingual) 0.4 mg (A) + 0.1 mg (B)

Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B)

23.5.3

Nicotine

(for nicotine replacement therapy)

P,S,T

Oral Dosage forms 2 mg Oral Dosage forms 4 mg

Section 24

Medicines acting on the Respiratory tract

24.1 – Antiasthmatic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

24.1.1

Budesonide*

P,S,T

Inhalation (MDI/DPI) 100 mcg/dose

Inhalation (MDI/DPI) 200 mcg/dose

Respirator solution for use in nebulizer 0.5 mg/mL Respirator solution for use in nebulizer 1 mg/mL

*Budesonide formulations are also listed in Section 16.1 – Ear, Nose and Throat Medicines

24.1.2

24.1.3

24.1.5

24.1.6

Medicine

Budesonide (A) + Formoterol (B)

Hydrocortisone*

Ipratropium

Level of Healthcare

P,S,T

Inhalation (MDI/DPI) 100 mcg (A)

+ 6 mcg (B)

Inhalation (MDI/DPI) 200 mcg (A)

+ 6 mcg (B)

Inhalation (MDI/DPI) 400 mcg (A)

+ 6 mcg (B)

Powder for Injection 100 mg Powder for Injection 200 mg

24.1.4

P,S,T

Inhalation (MDI/DPI) 20 mcg/dose

Respirator solution for use in nebulizer 250 mcg/mL

Montelukast

Salbutamol

S,T

P,S,T

Tablet 4 mg

Tablet 5 mg

(including chewable tablets) Tablet 10 mg

Tablet 2 mg

Tablet 4 mg

Oral liquid 2 mg/5 mL

Inhalation (MDI/DPI*) 100 mcg/dose

Respirator Solution

(Solution for Nebulizer 5 mg/mL)

*Hydrocortisone formulations are also listed in –

A. Section 3.5 – Antiallergics and Medicines used in Anaphylaxis

B. Section 18.1.3 – Hormones, other Endocrine Medicines and Contraceptives- Adrenal hormones and synthetic substitutes

Dosage form(s) and strength(s)

24.1.7

25.1.1

25.1.2

25.1.3

25.1.4

Medicine

Tiotropium

Glucose*

Oral rehydration salts**

Potassium chloride

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Inhalation (MDI) 9 mcg/dose Inhalation (DPI) 18 mcg/dose

MDI- Metered Dose Inhaler DPI- Dry Powder Inhaler

Section 25

Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

Injection 5 % Injection 10 % Injection 25 % Injection 50 %

Glucose(A) + Sodium chloride (B)

P,S,T

Injection 5% (A) + 0.9 % (B)

As licensed

S,T

*Glucose formulations are also listed in Section 18.4.2.1 – Hormones, other Endocrine Medicines and Contraceptives – Medicines used in diabetes mellitus – Medicines used to treat hypoglycemia

**Oral rehydration salts are also listed in Section 17.6.1 – Gastrointestinal Medicines – Medicines used in diarrhea

Oral liquid 500 mg/5 mL Injection 150 mg/mL

25.1.5

25.1.6

25.1.7

Medicine

Ringer lactate

Sodium bicarbonate

Sodium chloride

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

S,T

Injection (as per IP) Injection (as per IP) Injection 0.9% Injection 3%

25.2-Miscellaneous

25.2.1

26.1

26.3

Medicine

Water for Injection

Calcium carbonate

Calcium gluconate*

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Injection

Medicine

Section 26 Vitamins and Minerals

Level of Healthcare

Dosage form(s) and strength(s)

Ascorbic acid (Vitamin C)

Tablet 100 mg Tablet 500 mg

26.2

P,S,T

Tablet 625 mg (equivalent to elemental calcium 250 mg) Tablet 1250 mg (equivalent to elemental calcium 500 mg)

26.4

Cholecalciferol

P,S,T

Solid oral dosage form 1000 IU Solid oral dosage form 60000 IU Oral liquid 400 IU/mL

*Calcium Gluconate formulations are also listed in Section 4.2.2 – Antidotes and Other substances used in poisoning/Envenomation Specific

Injection 100 mg/mL

26.5

26.6

26.7

Medicine

Pyridoxine

Riboflavin

Thiamine

Vitamin A

Level of Healthcare

P,S,T

Dosage form(s) and strength(s)

Tablet 10 mg Tablet 50 mg Tablet 100 mg

Tablet 100 mg Injection 100 mg/mL

26.8

P,S,T

Capsule/Tablet 50000 IU (including Chewable Tablet)

Oral liquid 100000 IU/mL Injection 50000 IU/mL

Section 27

Medicines for COVID 19 management

27.1

27.2

Dexamethasone*

Enoxaparin**

P,S,T

S,T

Tablet 0.5 mg

Tablet 2 mg

Tablet 4 mg

Oral liquid 0.5 mg/5 mL (p) Injection 4 mg/mL

Injection 40 mg/ 0.4 mL Injection 60 mg/ 0.6 mL

*Dexamethasone is also listed in –

A. Section 3.4 – Antiallergics and Medicines used in Anaphylaxis

B. Section 7.4.3 – Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative are- Medicines used in Palliative Care

C. Section 18.1.1 – Hormones, other Endocrine Medicines and Contraceptives – Adrenal hormones and synthetic substitutes

**Enoxaparin is also listed in –

A. Section 8.2.1 – Medicines affecting Blood – Medicines affecting coagulation

B. Section 10.5.4 – Cardiovascular medicines – Antiplatelet and Antithrombotic Medicines

Tablet 10 mg

27.3

27.5

Medicine

Methylprednisolone *

Paracetamol**

Oxygen***

Level of Healthcare

S,T

P,S,T

Dosage form(s) and strength(s)

Injection 40 mg/mL

27.4

Tablet 500 mg

Tablet 650 mg

Oral liquid 120 mg/5 mL (p) Oral Liquid 125 mg/5 mL (p) Oral Liquid 250 mg/5 mL (p)

P,S,T

As licensed for medical purpose

*Methylprednisolone is also listed in Section 18.1.4 – Hormones, other Endocrine medicines and Contraceptives- Adrenal Hormones and synthetic substitutes

**Paracetamol is also listed in

A. Section 2.1.5 – Analgesics, antipyretics, non steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders- Non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory medicines

B. Section 5.2.3 – Medicines used in Neurological Disorders-Antimigraine medicines

*** Oxygen is also listed in Medicines used in Section 1.1.5 – Anaesthesia- General Anaesthetics and Oxygen

All modified release formulations of same strength such as sustained release, controlled release, extended release, prolonged release etc. are included.

Alphabetical List of Medicines in NLEM 2022

1. 5-aminosalicylic acid (Mesalazine/Mesalaine)

2. 5-Fluorouracil

3. 6-Mercaptopurine

4. Abacavir

5. Abacavir (A) + Lamivudine (B)

6. Acetazolamide

7. Acetylsalicylic acid

8. Actinomycin D

9. Activated Charcoal

10. Acyclovir

11. Adenosine

12. Adrenaline

13. Albendazole

14. Allopurinol

15. All-trans retinoic acid

16. Alprostadil

17. Amikacin

18. Amiodarone

19. Amitriptyline

20. Amlodipine

21. Amoxicillin

22. Amoxicillin (A) + Clavulanic acid (B)

23. Amphotericin B

a) Amphotericin B (conventional) b) Lipid Amphotericin B

c) Liposomal Amphotericin B

Alphabetical List of Medicines in NLEM 2022

24. Ampicillin

25. Anti-D immunoglobulin

26. Anti-rabies immunoglobulin

27. Anti-tetanus immunoglobulin

28. Arsenic trioxide

29. Artemether (A) + Lumefantrine (B)

30. Artesunate

31. Artesunate (A) + Sulphadoxine

32. Ascorbic acid (Vitamin C)

33. Atazanavir (A) + Ritonavir (B)

34. Atorvastatin

35. Atracurium

36. Atropine

37. Azathioprine

38. Azithromycin

39. Baclofen

40. Barium sulphate

41. BCG vaccine

42. Bedaquiline

43. Bendamustine Hydrochloride

44. Benzathine benzylpenicillin

45. Benzoyl peroxide

46. Benzylpenicillin

47. Betamethasone

48. Betamethasone (valerate)

49. Bicalutamide

Pyrimethamine (B)

Alphabetical List of Medicines in NLEM 2022

50. Bisacodyl

51. Bleomycin

52. Bortezomib

53. Budesonide

54. Budesonide (A) +Formoterol (B)

55. Bupivacaine

56. Buprenorphine

57. Buprenorphine (A) + Naloxone (B)

58. Caffeine

59. Calamine

60. Calcium carbonate

61. Calcium folinate

62. Calcium gluconate

63. Capecitabine

64. Carbamazepine

65. Carbimazole

66. Carboplatin

67. Carboxymethyl cellulose

68. Cefadroxil

69. Cefazolin

70. Cefixime

71. Cefotaxime

72. Ceftazidime

73. Ceftriaxone

74. Cefuroxime

75. Cetirizine

Alphabetical List of Medicines in NLEM 2022

76. Chlorambucil

77. Chlorhexidine

78. Chloroquine

79. Cholecalciferol

80. Ciprofloxacin

81. Cisplatin

82. Clarithromycin

83. Clindamycin

84. Clobazam

85. Clofazimine

86. Clomiphene citrate

87. Clomipramine

88. Clonazepam

89. Clopidogrel

90. Clotrimazole

91. Cloxacillin

92. Clozapine

93. Coagulation factor IX

94. Coagulation factor VIII

95. Coal tar (A) + Salicylic Acid (B)

96. Colchicine

97. Condom

98. Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)]

99. Cryoprecipitate

100. Cyclophosphamide

Alphabetical List of Medicines in NLEM 2022

101. Cycloserine

102. Cyclosporine

103. Cytosine arabinoside

104. D- Penicillamine

105. Dabigatran

106. Dacarbazine

107. Daclatasvir

108. Dapsone

109. Darunavir

110. Darunavir (A) + Ritonavir (B) 111. Daunorubicin

112. Delamanid

113. Desferrioxamine

114. Dexamethasone

115. Dextran-40

116. Diazepam

117. Diclofenac

118. Dicyclomine

119. Diethylcarbamazine

120. Digoxin

121. Diltiazem

122. Dinoprostone

123. Diphtheria antitoxin

124. Dobutamine

125. Docetaxel

Alphabetical List of Medicines in NLEM 2022

126. Dolutegravir

127. Domperidone

128. Donepezil

129. Dopamine

130. Doxorubicin

131. Doxycycline

132. DPT vaccine

133. DPT+ Hib+ Hep B vaccine 134. Efavirenz

135. Enalapril

136. Enoxaparin 137. Entecavir 138. Erythropoietin 139. Escitalopram 140. Esmolol

141. Ethambutol

142. Ethinylestradiol (A) + Levonorgestrel (B) 143. Ethionamide

144. Ethyl alcohol (Denatured)

145. Etoposide

146. Fentanyl

147. Ferrous Salts (A) + Folic Acid (B)

148. Ferrous salts

149. Filgrastim

150. Fluconazole

Alphabetical List of Medicines in NLEM 2022

151. Fludrocortisone 152. Flunarizine 153. Fluorescein 154. Fluoxetine

155. Fluphenazine

156. Folic Acid

157. Framycetin

158. Fresh frozen plasma 159. Furosemide

160. Fusidic acid

161. Gadobenate dimeglumine

162. Gefitinib

163. Gemcitabine

164. Gentamicin

165. Glimepiride

166. Glucose

167. Glucose(A) + Sodium chloride (B) 168. Glutaraldehyde

169. Glycerin

170. Glyceryl trinitrate

171. Glycopyrrolate

172. Griseofulvin

173. Haemodialysis fluid

174. Haloperidol

175. Halothane

Alphabetical List of Medicines in NLEM 2022

176. Heparin

177. Hepatitis B immunoglobulin

178. Hepatitis B vaccine

179. Homatropine

180. Hormone releasing IUD

181. Human chorionic gonadotropin

182. Human normal immunoglobulin

183. Hydrochlorothiazide

184. Hydrocortisone

185. Hydrogen Peroxide

186. Hydroxocobalamine

187. Hydroxychloroquine

188. Hydroxypropyl methylcellulose

189. Hydroxyurea

190. Hyoscine butylbromide

191. Ibuprofen

192. Ifosfamide

193. Imatinib

194. Insulin (Soluble)

195. Insulin Glargine

196. Insulin Intermediate Acting (NPH)

197. Insulin Premix Injection 30:70 (Regular : NPH) 198. Iohexol

199. Ipratropium

200. Irinotecan HCI Trihydrate

201. Iron sucrose

Alphabetical List of Medicines in NLEM 2022

202. Isoflurane

203. Isoniazid

204. Isosorbide dinitrate

205. Ispaghula

206. Itraconazole

207. IUD containing Copper

208. Ivermectin

209. Japanese Encephalitis Vaccine 210. Ketamine

211. Labetalol

212. Lactulose

213. Lamivudine

214. L-Asparaginase

215. Latanoprost

216. Lenalidomide

217. Letrozole

218. Leuprolide acetate

219. Levetiracetam

220. Levodopa (A) + Carbidopa (B) 221. Levofloxacin

222. Levonorgestrel

223. Levothyroxine

224. Lignocaine

225. Lignocaine (A) + Adrenaline (B) 226. Linezolid

Alphabetical List of Medicines in NLEM 2022

227. Lithium

228. Loperamide

229. Lopinavir (A) + Ritonavir (B)

230. Lorazepam

231. Magnesium sulphate

232. Mannitol

233. Measles vaccine

234. Mebendazole

235. Medroxyprogesterone acetate

236. Mefenamic acid

237. Mefloquine

238. Meglumine diatrizoate

239. Melphalan

240. Meropenem

241. Mesna

242. Metformin

243. Methotrexate

244. Methylergometrine

245. Methylprednisolone

246. Methylrosanilinium chloride (Gentian Violet) 247. Methylthioninium chloride (Methylene blue) 248. Metoclopramide

249. Metoprolol

250. Metronidazole

251. Midazolam

252. Mifepristone

253. Miltefosine

Alphabetical List of Medicines in NLEM 2022

254. Misoprostol

255. Montelukast

256. Morphine

257. Moxifloxacin

258. Mupirocin

259. Mycophenolate mofetil 260. N-acetylcysteine

261. Naloxone

262. Natamycin

263. Neostigmine

264. Nevirapine

265. Nicotine replacement therapy (NRT) 266. Nifedipine

267. Nitrofurantoin 268. Nitrous oxide 269. Noradrenaline 270. Norethisterone 271. Nystatin

272. Omeprazole

273. Ondansetron

274. Oral poliomyelitis vaccine 275. Oral rehydration salts

276. Ormeloxifene (Centchroman) 277. Oxaliplatin

278. Oxygen

Alphabetical List of Medicines in NLEM 2022

279. Oxytocin

280. Paclitaxel

281. Pantoprazole

282. Para- aminosalicylic acid 283. Paracetamol

284. Paromomycin

285. Peritoneal dialysis solution

286. Permethrin

287. Pheniramine

288. Phenobarbitone

289. Phenoxymethyl penicillin

290. Phenylephrine

291. Phenytoin

292. Phytomenadione(Vitamin K1)

293. Pilocarpine

294. Piperacillin (A) + Tazobactam (B)*

295. Platelet rich plasma/ Platelet concentrates 296. Podophyllin resin

297. Potassium chloride

298. Potassium permanganate

299. Povidone iodine

300. Pralidoxime chloride (2-PAM)

301. Praziquantel

302. Prednisolone

303. Primaquine

304. Procaine Benzylpenicillin

Alphabetical List of Medicines in NLEM 2022

305. Proparacaine

306. Propofol

307. Propranolol

308. Protamine Sulphate 309. Pyrazinamide

310. Pyridoxine 311. Quinine

312. Rabies vaccine 313. Raltegravir 314. Ramipril

315. Red blood cells/ Packed RBCs 316. Ribavirin

317. Riboflavin

318. Rifampicin

319. Ringer lactate 320. Risperidone

321. Ritonavir

322. Rituximab

323. Rotavirus vaccine 324. Salbutamol

325. Salicylic acid

326. Sevoflurane

327. Silver sulphadiazine

Alphabetical List of Medicines in NLEM 2022

328. Snake Venom Antiserum

a. Soluble/ liquid polyvalent b. Lyophilized polyvalent

329. Sodium bicarbonate

330. Sodium chloride

331. Sodium nitrite

332. Sodium nitroprusside

333. Sodium thiosulphate

334. Sodium Valproate

335. Sofosbuvir

336. Somatostatin

337. Spironolactone

338. Streptokinase

339. Streptomycin

340. Succinylcholine

341. Sulfasalazine

342. Sumatriptan

343. Surfactant

344. Tacrolimus

345. Tamoxifen

346. Telmisartan

347. Temozolomide

348. Tenecteplase

349. Teneligliptin

350. Tenofovir (A) + Lamivudine (B)

Alphabetical List of Medicines in NLEM 2022

351. Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) 352. Tenofovir (A) + Lamivudine (B) + Efavirenz (C) 353. Tenofovir Alafenamide Fumarate (TAF)

354. Tenofovir Disproxil Fumarate (TDF)

355. Terbinafine

356. Tetanus toxoid

357. Thalidomide

358. Thiamine

359. Thiopentone

360. Timolol

361. Tiotropium

362. Tramadol

363. Tranexamic acid

364. Trastuzumab

365. Trihexyphenidyl

366. Tropicamide

367. Tuberculin, Purified Protein derivative 368. Valganciclovir

369. Vancomycin

370. Vecuronium

371. Verapamil

372. Vinblastine

373. Vincristine

374. Vitamin A

Alphabetical List of Medicines in NLEM 2022

375. Warfarin

376. Water for Injection

377. Whole blood

378. Xylometazoline

379. Zidovudine

380. Zidovudine (A) + Lamivudine (B)

381. Zidovudine (A) + Lamivudine (B) + Nevirapine (C) 382. Zinc Sulphate

383. Zoledronic acid

384. Zolpidem

Medicines Added Therapeutic category wise in NLEM 2022

Section 1 Medicines used in Anaesthesia

NIL

Section 2

Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders

NIL

Section 3

Antiallergics and medicines used in anaphylaxis

NIL

Section 4

Antidotes and Other Substances used in Management of Poisonings/Envenomation

NIL

Section 5

Medicines used in Neurological disorders

NIL

Section 6 Anti-infective medicines

6.1.2 -Antifilarial

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.1.5

Ivermectin

P,S,T

Tablet 6 mg Tablet 12 mg

6.2-Antibacterials

6.2.1 Beta-lactam Medicines

6.2.1.14

Meropenem

Powder for Injection 500 mg (as trihydrate)

Powder for Injection 1000 mg (as trihydrate)

6.2.2 – Other antibacterials

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.2.2.2

Cefuroxime

P,S,T

Tablet 500 mg

Syrup 125 mg/ 5 mL (p) Injection 1500 mg

6.2.2.11

Phenoxymethyl penicillin

P,S,T

Tablet 250 mg

6.2.2.12

Procaine Benzylpenicillin

P,S,T

Powder for injection 1000 mg (=1 million IU)

6.4-Antituberculosis medicines

6.5-Antifungal medicines

Dosage form(s) and strength(s)

Tablet 100 mg Tablet 50 mg

6.4.1

6.4.2

6.4.7

Medicine

Amikacin

Bedaquiline

Delamanid

Level of Healthcare

S,T

Injection 100 mg/mL Injection 250 mg/mL Injection 500 mg/mL

6.5.5

6.5.6

6.5.8

Medicine

Itraconazole

Mupirocin

Terbinafine

Medicine

Level of Healthcare

S,T

P,S,T

Dosage form(s) and strength(s)

Capsule 100 mg Capsule 200 mg

Oral liquid 10 mg/mL

P,S,T

Ointment 2%

Cream 1%

6.6.2 – Anti-Cytomegalovirus (CMV) medicines

Level of Healthcare

Dosage form(s) and strength(s)

6.6.2.1

Valganciclovir

S, T

Tablet 450 mg

Powder for oral solution 50 mg/mL

6.7- Medicines used in the Management of HIV

6.7.1.3

Lamivudine

S,T

Tablet 100 mg Tablet 150 mg

6.7.1.5

Tenofovir (A) + Lamivudine (B) + Dolutegravir (C)

P,S,T

Tablet 300 mg (A) + 300 mg (B) + 50 mg (C)

6.7.3 – Integrase inhibitors

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.7.3.1

Dolutegravir

S,T

Tablet 50 mg

6.7.4-Protease inhibitors

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.7.4.3

Darunavir (A) + Ritonavir (B)

S,T

Tablet 600 mg (A) + Tablet 100 mg (B)

6.8 – Medicines for hepatitis B and hepatitis C

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.8.1

Daclatasvir

S,T

Tablet 60 mg Tablet 30 mg

6.8.5

Tenofovir Alafenamide Fumarate (TAF)

S,T

Tablet 25 mg

Section 7 Antimigraine medicines

(Now in Section 5 Medicines used in Neurological Disorders)

NIL

Section 8

Anti-cancer agents including Immunosuppressives and Medicines used in Palliative Care

(Now in Section 7)

7.1- Antineoplastic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.1.6

Bendamustine Hydrochloride

Injection 25 mg Injection 100 mg/vial

7.1.26

Irinotecan HCI Trihydrate

Solution for injection 20 mg/ mL

7.1.28

Lenalidomide

Capsule 5 mg Capsule 25 mg

7.2-Hormones and anti-hormones used in cancer therapy

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

7.2.3

Leuprolide acetate

Powder for injection 3.75 mg Powder for injection 11.25 mg Powder for injection 22.5 mg

Section 8 Medicines affecting Blood

NIL

Section 9

Antiparkinsonism medicines

(Now in Section 5.3 Medicines used in Neurological Disorders)

NIL

Section 10 Medicines affecting Blood

NIL

Section 11

Blood products and Plasma substitutes

NIL

Section 12 Cardiovascular Medicines

(Now in Section 10)

10.5- Antiplatelet and Antithrombotic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

10.5.3

Dabigatran

S, T

Tablet 110 mg Tablet 150 mg

10.5.7

Tenecteplase

S,T

Injection 30 mg/vial Injection 40 mg/vial

Section 13 Dermatological medicines (Topical)

NIL

Section 14 Dermatological medicines (Topical)

NIL

Section 15 Diagnostic Agents

NIL

Section 16 Dialysis solutions

NIL

Section 17 Disinfectants and Antiseptics and

NIL

Section 18 Diuretics

NIL

18.1-Adrenal Hormones and Synthetic substitutes

Dosage form(s) and strength(s)

18.2 – Contraceptives

18.2.1 – Hormonal Contraceptives

Section 19

Ear, Nose and Throatmedicines

Section 20 Gastrointestinal medicines

Section 21

Hormones, other Endocrine Medicines and Contraceptives (Now in Section 18)

18.1.2

Medicine

Fludrocortisone

Level of Healthcare

S,T

Tablet 100 mcg

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

18.2.3

Ormeloxifene

P,S,T

Tablet 30 mg

18.3.1.4

18.3.1.7

(Centchroman)

18.3 Medicines used in diabetes mellitus

18.3.1 Insulins and other antidiabetic agents

Insulin Glargine

Teneligliptin

P,S,T

Injection 100 IU/mL

P,S,T

Tablet 20 mg

19.4.8

Section 22 Immunologicals (Now in Section 19)

For universal immunization

Medicine

Level of Healthcare

Rotavirus vaccine

P, S, T

As licensed

Section 23

Muscle relaxants and cholinesterase inhibitors

(Now in Section 1- Medicines used in Anaesthesia) (sub-section 1.4 – Muscle relaxants and cholinesterase inhibitors)

NIL

Dosage form(s) and strength(s)

Section 24 Medicines for neonatal care

NIL

Section 25 Ophthalmological Medicines (Now in Section 21)

21.4-Miotics and Antiglaucoma Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

21.4.2

Latanoprost

P,S,T

Drops 0.005 %

Section 26 Oxytocics and Antioxytocic

NIL

Section 27

Medicines used in treatment of Psychiatric Disorders (Now in Section 23)

23.5-Medicines for disorders due to psychoactive substance abuse

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

23.5.1

Buprenorphine

P,S,T

Tablet (Sub-lingual) 0.4 mg

23.5.2

Buprenorphine (A) + Naloxone (B)

P,S,T

Tablet (Sub-lingual) 0.4 mg (A) + 0.1 mg (B)

Tablet (Sub-lingual) 2 mg (A) + 0.5 mg (B)

23.5.3

Nicotine (for nicotine replacement therapy)

P,S,T

Oral Dosage forms 2 mg Oral Dosage forms 4 mg

Section 28

Medicines acting on the respiratory tract (Now in Section 24)

24.1-Antiasthmatic Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

24.1.8

Montelukast

S,T

Tablet 4 mg

Tablet 5 mg

(including chewable tablets) Tablet 10 mg

Section 29

Solutions correcting Water, Electrolyte disturbances and Acid-base disturbances

(Now in Section 25)

NIL

Section 30 Vitamins and minerals (Now in Section 26)

NIL

Alphabetical List of Medicines Added to NLEM 2022

1. Amikacin

2. Bedaquiline

3. Bendamustine Hydrochloride

4. Buprenorphine

5. Buprenorphine (A) + Naloxone (B)

6. Cefuroxime

7. Dabigatran

8. Daclatasvir

9. Darunavir (A) + Ritonavir (B)

10. Delamanid

11. Dolutegravir

12. Fludrocortisone

13. Insulin Glargine

14. Irinotecan HCI Trihydrate

15. Itraconazole

16. Ivermectin

17. Lamivudine

18. Latanoprost

Alphabetical List of Medicines Added to NLEM 2022

19. Lenalidomide

20. Leuprolide acetate

21. Meropenem

22. Montelukast

23. Mupirocin

24. Nicotine replacement therapy (NRT)

25. Ormeloxifene (Centchroman)

26. Phenoxymethyl penicillin

27. Procaine Benzyl penicillin

28. Rotavirus vaccine

29. Tenecteplase

30. Teneligliptin

31. Tenofovir (A) + Lamivudine (B) + Dolutegravir (C) 32. Tenofovir Alafenamide Fumarate (TAF)

33. Terbinafine

34. Valganciclovir

Medicines Deleted from Therapeutic category wise

NLEM 2015

Medicines Deleted from Therapeutic category wise NLEM 2015

Section 1 Anaesthetic Agents

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

1.2.4

Prilocaine (A) + Lignocaine (B)

Cream 2.5% (A) + 2.5% (B)

Section 2-Analgesics, antipyretics, non-steroidal anti-inflammatory medicines, medicines used to treat Gout and disease Modifying agents used in Rheumatoid Disorders

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

2.4.3

Leflunomide

S,T

Tablet 10 mg Tablet 20 mg

Section 3-Antiallergics and medicines used in anaphylaxis

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

3.3

Chlorpheniramine

P,S,T

Tablet 4 mg

Oral liquid 2 mg/5 ml

Section 4-Antidotes and Other substances used in poisoning treatment

4.2 Specific

Medicine

Level of

Dosage form(s) and strength(s)

4.2.4

Dimercaprol

Healthcare

Section 5 Medicines used in Neurological Disorders

S,T

NIL

6.2.4-Antituberculosis medicines

6.2.4.1

Medicine

Section 6-Anti-infective medicines

Capreomycin

Level of Healthcare

Dosage form(s) and strength(s)

P,S,T

Powder for Injection 1 g

6.2.4.6

6.2.4.12

Kanamycin

Rifabutin

P,S,T

S,T

Powder for Injection 500 mg Powder for Injection 750 mg Powder for Injection 1 g

Capsule 150 mg

6.4.2-Anti Cytomegalovirus (CMV) medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.4.2.1

Ganciclovir

S,T

Capsule 250 mg

Powder for Injection 500 mg

Injection 50 mg/ml

6.4.3-Medicines used in the management of HIV

6.4.3.1 -Nucleoside reverse transcriptase inhibitors

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.4.3.1.3

Lamivudine (A) + Nevirapine (B) + Stavudine (B)

S,T

Dispersible Tablet 30mg (A) + 50mg (B) + 6mg (C)

Tablet 150mg (A) + 200mg (B) + 30mg (C)

6.4.3.1.5

Stavudine (A) + Lamivudine (B)

S,T

Dispersible Tablet 6 mg (A) + 30 mg (B) (p)

Tablet 30 mg (A) + 150 mg (B)

6.4.4-Medicines for hepatitis B and hepatitis C

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.4.4.2

Pegylated interferon alfa 2a

S,T

Injection 180 mcg

Pegylated interferon alfa 2b

S,T

Injection 80 mcg Injection 100 mcg Injection 120 mcg

6.5.1 Antiamoebic and antigiardiasis medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

6.5.1.1

Diloxanide furoate

P,S,T

Tablet 500 mg

6.5.4-Antipneumocystosis and antitoxoplasmosis medicines

6.5.4.2

Pentamidine

S,T

Powder for Injection 200 mg

Section 7 Antimigraine medicines

NIL

Section 8 Anti-cancer agents including Immunosuppressives, and Medicines used in Palliative Care

NIL

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

8.1.30

Procarbazine

Capsule 50 mg

Section 9 Antiparkinsonism medicines

NIL

Section 10 Medicines affecting blood

NIL

10.3-Antihypertensive Medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

12.3.6

Methyldopa

P,S,T

Tablet 250 mg Tablet 500 mg

Section 11 Blood products and Plasma substitutes

NIL

Section 12- Cardiovascular Medicines

12.3-Antihypertensive medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

12.3.2

Atenolol

P,S,T

Tablet 50 mg Tablet 100 mg

12.5-Antithrombotic medicine (Cardiovascular/ Cerebrovascular)

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

12.5.2

Alteplase

Powder for Injection 20 mg Powder for Injection 50 mg

Section 13 Dermatological medicines (Topical)

NIL

Section 14 Dermatological medicines (Topical)

14.6 Miscellaneous

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

14.6.2

White Petrolatum

P,S,T

Jelly 100%

Section 15 Diagnostic agents

NIL

Section 16 Dialysis solutions

NIL

Section 17 Antiseptics and Disinfectants

17.1- Antiseptics

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

17.1.1

Cetrimide

P,S,T

Solution 20 % (Concentrate for dilution)

17.2 Disinfectants

17.2.1

Bleaching powder

P,S,T

Containing not less than 30%w/w of available chlorine (as per I.P)

Section 18 Diuretics

NIL

Section 19 Ear, Nose and Throatmedicines

NIL

Section 20 Gastrointestinal medicines

20.1 Antiulcer medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

20.1.4

Sucralfate

S,T

Oral liquid 1g

20.1.3

Ranitidine

P,S,T

Tablet 150 mg

Oral liquid 75 mg/5 mL Injection 25 mg/mL

Section 21 Hormones, other Endocrine Medicines and Contraceptives

21.2.1 Hormonal contraceptives

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

21.2.1.2

Ethinylestradiol (A) + Norethisterone (B)

P,S,T

Tablet 0.035 mg (A) +1 mg (B)

21.3 Estrogens

21.3.1

Ethinylestradiol

P,S,T

Tablet 0.01 mg Tablet 0.05 mg

Section 22 Immunologicals

NIL

Section 23 Muscle relaxants and cholinesterase inhibitors

NIL

Section 24 Medicines for neonatal care

NIL

Section 25 Ophthalmological Medicines

25.1-Anti-infective medicines

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

25.1.3

Erythromycin

P,S,T

Ointment 0.5 %

Section 26 Oxytocics and Antioxytocics

NIL

Section 27 Medicines in treatment of Psychiatric Disorders

NIL

Section 28 Medicines acting on the respiratory tract

NIL

Section 29 Solutions correcting water, electrolyte disturbances and acid-base disturbances

NIL

Section 30 Vitamins and minerals

Medicine

Level of Healthcare

Dosage form(s) and strength(s)

30.5

Nicotinamide

P,S,T

Tablet 50 mg

Alphabetical List of Medicines Deleted from NLEM 2015

1. Alteplase

2. Atenolol

3. Bleaching Powder

4. Capreomycin

5. Cetrimide

6. Chlorpheniramine

7. Diloxanide furoate

8. Dimercaprol

9. Erythromycin

10. Ethinylestradiol

11. Ethinylestradiol(A) Norethisterone (B)

12. Ganciclovir

13. Kanamycin

14. Lamivudine (A) + Nevirapine (B) + Stavudine (C)

15. Leflunomide

16. Methyldopa

17. Nicotinamide

18. Pegylated interferon alfa 2a, Pegylated interferon alfa 2b

19. Pentamidine

20. Prilocaine (A) + Lignocaine (B)

21. Procarbazine

22. Ranitidine

23. Rifabutin

24. Stavudine (A) + Lamivudine (B) 25. Sucralfate

26. White Petrolatum

5-aminosalicylic acid, 61 5-Fluorouracil, 37 6-Mercaptopurine, 37 Abacavir, 28

Abacavir (A) + Lamivudine (B), 29 Acetazolamide, 72

Acetylsalicylic acid, 6, 15, 52 Actinomycin D, 37

Benzoyl peroxide, 55 Benzylpenicillin, 20 Betamethasone, 74 Betamethasone (valerate), 54 Bicalutamide, 40

Bisacodyl, 61

Bleomycin, 37

Bortezomib, 37

Budesonide, 59, 78

Budesonide (A) +Formoterol (B), 79 Bupivacaine, 4

Buprenorphine, 78

Buprenorphine (A) + Naloxone (B), 78 Caffeine, 70

Calamine, 55

Calcium carbonate, 81

Calcium folinate, 37

Calcium gluconate, 11, 81 Capecitabine, 37

Carbamazepine, 13, 76

Carbimazole, 67

Carboplatin, 41

Carboxymethyl cellulose, 73 Cefadroxil, 20

Cefazolin, 20

Cefixime, 20

Cefotaxime, 20, 31

Ceftazidime, 21

Ceftriaxone, 21

Cefuroxime, 21

Cetirizine, 9

Chlorambucil, 38

Chlorhexidine, 57

Chloroquine, 36

Cholecalciferol, 81

Ciprofloxacin, 22, 59, 71

Cisplatin, 38

Clarithromycin, 22, 24

Clindamycin, 22, 31, 34, 36 Clobazam, 13

Clofazimine, 24, 25

Clomiphene citrate, 66

Clomipramine, 77

Clonazepam, 77

Clopidogrel, 53

Activated Charcoal, 11

Acyclovir, 28, 31, 71

Adenosine, 50

Adrenaline, 9

Albendazole, 18

Allopurinol, 8, 42

All-trans retinoic acid, 37

Alprostadil, 70

Amikacin, 24

Amiodarone, 50

Amitriptyline, 16, 42, 75

Amlodipine, 50

Amoxicillin, 19

Amoxicillin (A) + Clavulanic acid (B), 19 Amphotericin B, 26, 34

Ampicillin, 20

Anti-D immunoglobulin, 68

Anti-rabies immunoglobulin, 68

Anti-tetanus immunoglobulin, 68

Arsenic trioxide, 37

Artemether (A) + Lumefantrine (B), 35 Artesunate, 35

Artesunate (A) + Sulphadoxine – Pyrimethamine

(B), 35

Ascorbic acid, 81

Atazanavir (A) + Ritonavir (B), 30 Atorvastatin, 53

Atracurium, 5

Atropine, 4, 11, 72

Azathioprine, 9, 41

Azithromycin, 21, 32

Baclofen, 5

Barium sulphate, 56

BCG vaccine, 69

Bedaquiline, 24

Bendamustine Hydrochloride, 37 Benzathine benzylpenicillin, 20

INDEX

Clotrimazole, 27, 32, 54, 59 Cloxacillin, 21

Clozapine, 74

Coagulation factor IX, 48 Coagulation factor VIII, 48

Coal tar (A) + Salicylic Acid (B), 55 Colchicine, 8

Condom, 65

Co-trimoxazole [Sulphamethoxazole (A) +

Trimethoprim (B)], 22, 35 Cryoprecipitate, 48 Cyclophosphamide, 38 Cycloserine, 25 Cyclosporine, 41

Cytosine Arabinoside, 38 D- Penicillamine, 11 Dabigatran, 53 Dacarbazine, 38 Daclatasvir, 32

Dapsone, 24

Darunavir, 31

Darunavir (A) + Ritonavir (B), 31 Daunorubicin, 38

Delamanid, 25

Desferrioxamine, 11 Dexamethasone, 10, 42, 63, 82 Dextran-40, 48

Diazepam, 13, 43

Diclofenac, 7

Dicyclomine, 61 Diethylcarbamazine (DEC), 11 Digoxin, 50, 51

Diltiazem, 49

Dinoprostone, 73

Diphtheria antitoxin, 68 Dobutamine, 52

Docetaxel, 38

Dolutegravir, 30

Domperidone, 60

Donepezil, 17

Dopamine, 52

Doxorubicin, 38

Doxycycline, 23, 36

DPT vaccine, 69

DPT+ Hib+ Hep B vaccine, 69

Efavirenz, 30

Enalapril, 51

Enoxaparin, 46, 53, 82

Entecavir, 32

Erythropoietin, 45

Escitalopram, 76

Esmolol, 50

Ethambutol, 25

Ethinylestradiol (A)+ Levonorgestrel (B), 64 Ethionamide, 25

Ethyl alcohol (Denatured), 57 Etoposide, 38

Fentanyl, 7

Ferrous Salt (A)+ Folic acid (B), 45 Ferrous salts, 45

Filgrastim, 43 Fluconazole, 27 Fludrocortisone, 63 Flunarizine, 17 Fluorescein, 56 Fluoxetine, 43, 76, 77 Fluphenazine, 74 Folic Acid, 46 Framycetin, 54

Fresh Frozen Plasma, 47 Furosemide, 58

Fusidic acid, 54

Gadobenate dimeglumine, 56 Gefitinib, 38

Gemcitabine, 39

Gentamicin, 23

Glimepiride, 65

Glucose(A) + Sodium chloride (B), 80 Glucose, 66, 80

Glutaraldehyde, 58

Glycerin (as mentioned in IP), 55 Glyceryl trinitrate, 49 Glycopyrrolate, 5

Griseofulvin, 27

Haemodialysis fluid, 57 Haloperidol, 75

Halothane, 3

Heparin, 46, 53

Hepatitis B immunoglobulin, 68 Hepatitis B vaccine, 69

Homatropine, 73

Hormone Releasing IUD, 65

Human chorionic gonadotropin, 66 Human normal immunoglobulin, 58 Hydrochlorothiazide, 51, 58 Hydrocortisone, 10, 63, 79

Hydrogen peroxide, 57 Hydroxocobalamin, 46 Hydroxychloroquine, 9 Hydroxypropyl methylcellulose, 73 Hydroxyurea, 39, 46

Hyoscine butyl bromide, 61 Ibuprofen, 7, 16

Ifosfamide, 39

Imatinib, 39

Insulin (Soluble), 65

Insulin Glargine, 66

Insulin Intermediate Acting (NPH), 65 Insulin Premix, 66

Iohexol, 56

Ipratropium, 79

Irinotecan HCI Trihydrate, 39

Iron sucrose, 46

Isoflurane, 3

Isoniazid, 25

Isosorbide dinitrate, 49

Isosorbide-5- mononitrate, 53 Ispaghula, 61

Itraconazole, 27

IUD containing Copper, 65 Ivermectin, 19

Japanese Encephalitis vaccine, 69 Ketamine, 3

Labetalol, 51

Lactulose, 43, 62

Lamivudine, 29

L-Asparaginase, 39

Latanoprost, 72

Lenalidomide, 39

Letrozole, 40

Leuprolide acetate, 41

Levetiracetam, 13

Levodopa (A) + Carbidopa (B), 17 Levofloxacin, 25

Levonorgestrel, 64

Levothyroxine, 67

Lignocaine, 4, 50

Lignocaine (A) + Adrenaline (B), 4

Linezolid, 25

Lithium, 76

Loperamide, 43

Lopinavir (A) + Ritonavir (B), 31

Lorazepam, 13

Magnesium sulphate, 14

Mannitol, 58

Measles vaccine, 70

Mebendazole, 18

Medroxyprogesterone acetate, 67

Mefenamic acid, 7

Mefloquine, 36

Meglumine diatrizoate, 56

Melphalan, 39

Meropenem,

Mesna, 44

Metformin, 66

Methotrexate, 9, 39

Methylergometrine, 73

Methylprednisolone, 63, 83 Methylrosanilinium chloride, 57 Methylthioninium chloride, 11 Metoclopramide, 44, 60

Metoprolol, 49

Metronidazole, 25, 33

Midazolam, 5, 14, 44

Mifepristone, 74

Miltefosine, 34

Misoprostol, 74

Montelukast, 79

Morphine, 5, 8, 44

Moxifloxacin, 25

Mupirocin, 27

Mycophenolate mofetil, 42

N-acetylcysteine, 12

Naloxone, 12

Natamycin, 71

Neostigmine, 6, 12

Nevirapine, 30

Nicotine (for nicotine replacement therapy), 78 Nifedipine, 74

Nitrofurantoin, 23

Nitrous oxide, 3 Noradrenaline, 52 Norethisterone, 67

Nystatin, 27

Omeprazole, 60

Ondansetron, 44, 60

Oral poliomyelitis vaccine, 70 Oral rehydration salts, 62, 80 Ormeloxifene, 64

Oxaliplatin, 40

Oxygen, 3, 83

Oxytocin, 74

Paclitaxel, 40

Pantoprazole, 60

Para- aminosalicylic acid, 26 Paracetamol, 7, 16, 83 Paromomycin, 34

Peritoneal dialysis solution, 57 Permethrin, 55

Pheniramine, 10 Phenobarbitone, 14 Phenoxymethyl penicillin, 23 Phenylephrine, 73

Phenytoin, 14

Phytomenadione, 46

Pilocarpine, 72

Piperacillin (A) + Tazobactam (B), 21 Platelet rich plasma/ Platelet concentrates, 47 Podophyllin resin, 55

Potassium chloride, 80

Potassium permanganate, 58 Povidone iodine, 57, 71 Pralidoxime chloride (2-PAM), 12 Praziquantel, 19

Prednisolone, 10, 41, 64, 71 Primaquine, 36

Procaine Benzylpenicillin, 23 Proparacaine, 56, 72

Propofol, 3

Propranolol, 17

Protamine Sulphate, 46 Pyrazinamide, 26

Pyridoxine, 82

Quinine, 36

Rabies vaccine, 70

Raltegravir, 30 Ramipril, 51

Red blood cells, 47 Ribavirin, 33 Riboflavin, 82 Rifampicin, 24, 26 Ringer lactate, 81 Risperidone, 75 Ritonavir, 31 Rituximab, 40 Rotavirus vaccine, 70 Salbutamol, 79 Salicylic acid, 55 Sevoflurane, 3

Silver sulphadiazine

Snake Venom Antiserum, 12, 68

Sodium bicarbonate, 81

Sodium chloride, 81

Sodium nitrite, 12

Sodium Nitroprusside, 51

Sodium thiosulphate, 12

Sodium Valproate, 15, 76

Sofosbuvir, 33

Somatostatin, 62

Spironolactone, 52, 58

Streptokinase, 53

Streptomycin, 26

Succinylcholine, 6

Sulfasalazine, 9

Sumatriptan, 16

Surfactant, 70

Tacrolimus, 42

Tamoxifen, 41

Telmisartan, 51

Temozolomide, 40

Tenecteplase, 53

Teneligliptin, 66

Tenofovir Disoproxil fumarate (A) + Lamivudine

(B), 29

Tenofovir Disoproxil fumarate (A) + Lamivudine

(B) + Dolutegravir (C), 29

Tenofovir Disoproxil fumarate (A) + Lamivudine

(B) + Efavirenz (C), 29

Tenofovir Alafenamide Fumarate (TAF), 33 Tenofovir Disproxil Fumarate (TDF), 29, 33

Terbinafine, 27

Tetanus toxoid, 70

Thalidomide, 40

Thiamine, 82

Thiopentone, 3

Timolol, 72

Tiotropium, 80

Tramadol, 8, 45

Tranexamic acid, 46

Trastuzumab, 40

Trihexyphenidyl, 17

Tropicamide, 56, 73

Tuberculin Purified Protein derivative, 68 Valganciclovir, 28, 32

Vancomycin, 23

Vecuronium, 6

Verapamil, 50

Vinblastine, 40

Vincristine, 40

Vitamin A, 82

Warfarin, 47

Water for Injection, 81

Whole blood, 47

Xylometazoline, 59

Zidovudine, 29

Zidovudine (A) + Lamivudine (B), 29 Zidovudine (A) + Lamivudine (B) + Nevirapine

(C),30

Zinc Sulphate, 62 Zoledronic acid, 45 Zolpidem, 77